syndrome	score	normalized_score
DRAVET SYNDROME	2.6655186999999994	100.0
CHILDHOOD ABSENCE EPILEPSY	1.5207408500000001	57.052342195160755
SECKEL SYNDROME 10; SCKL10	1.25	46.89518779215469
MYOCLONIC-ASTASTIC EPILEPSY	1.22839834	46.08477667029687
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.78280343709463
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1521162600000001	43.222966696875936
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	1.0172660199999999	38.16390483398223
TRICARBOXYLIC ACID CYCLE, DEFECT OF	1.0172414	38.162981186363474
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	1.014250339	38.05076809252924
PAROXYSMAL KINESIGENIC DYSKINESIA	1.00980392	37.883955569323156
SENGERS SYNDROME	1.00684932	37.7731103518426
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	1.00537634	37.71784981287133
LOWRY-MACLEAN SYNDROME	1.000541419	37.53646219026714
SPLENOPORTAL VASCULAR ANOMALIES	1.0	37.51615023372375
CHIARI MALFORMATION TYPE II	1.0	37.51615023372375
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	1.0	37.51615023372375
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	1.0	37.51615023372375
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	37.51615023372375
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.056619936675
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.933333	35.015061046092086
LAFORA DISEASE	0.7769053	29.14649595217622
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.91058689627652
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7480334099999999	28.06333378940467
EARLY MYOCLONIC ENCEPHALOPATHY	0.7178920999999999	26.932547875203426
GITELMAN SYNDROME	0.7063864400000001	26.500899806105288
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.67941163	25.488908781619134
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.6510022200000001	24.423097088007683
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.6459959190000001	24.23527994757644
GLUTARIC ACIDEMIA I; GA1	0.628735789	23.587746317442836
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.6118624890000001	22.95472505970415
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.6103603	22.898368711500698
PAROXYSMAL HEMICRANIA	0.6098039199999999	22.877495475833655
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.6055556000000001	22.718114864472728
ROLANDIC EPILEPSY	0.60042522	22.525642757636632
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.5999174890000001	22.506594645162316
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.5927414099999999	22.23737578730924
HSD10 DISEASE	0.583874419	21.90472042083217
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.84230735278654
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.535437929	20.08756978519791
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	20.00860095260259
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.52601025	19.733879563478588
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.52412562	19.663175501263602
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.5209282599999999	19.543222863152305
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.50980392	19.12588045246128
GLYCINE ENCEPHALOPATHY	0.50925926	19.10544690607498
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.50925926	19.10544690607498
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.022273225845318
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.50392157	18.90519732613394
INHALATIONAL ANTHRAX	0.50373134	18.898060628874976
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.5	18.758075116861875
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.5	18.758075116861875
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.5	18.758075116861875
RENAL TUBULAR ACIDOSIS III	0.5	18.758075116861875
BARTH SYNDROME; BTHS	0.5	18.758075116861875
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.758075116861875
CREST SYNDROME	0.5	18.758075116861875
TRIGEMINAL NEURALGIA	0.5	18.758075116861875
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.5	18.758075116861875
CLUSTER HEADACHE, FAMILIAL	0.5	18.758075116861875
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.47878750000000003	17.962263780029012
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.457390739	17.15953967983793
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.45148625	16.93802598346056
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42074085000000006	15.784576938064632
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.41458575	15.553661281761036
SPINOCEREBELLAR ATAXIA TYPE 10	0.4088913	15.34002744006261
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.38836981000000004	14.570140138202751
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.37769549	14.169680745439909
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.3655911	13.715570631712323
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.676884352752808
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769368
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769368
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.35559819	13.340675118880242
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.307012252437026
ACUTE ADRENAL INSUFFICIENCY	0.35423968899999997	13.289709391271575
GLUTATHIONE SYNTHETASE DEFICIENCY	0.3505744	13.152201858497564
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.35054141899999997	13.150964538346704
INSULINOMA	0.349748019	13.12119922475127
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.34717764999999995	13.024768875191159
HYDROXYKYNURENINURIA	0.3437497	12.896165387997469
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.34371794999999994	12.894974250227545
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34259226	12.852742695070946
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.34054108899999996	12.77579065567989
ADDISON DISEASE	0.34054108899999996	12.77579065567989
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.76956901484128
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.34018232	12.762331023976687
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.338945789	12.715941141212031
COG4-CDG	0.33725457	12.6524931151299
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.333874419	12.52568286240123
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.333874419	12.52568286240123
GLUTATHIONE SYNTHETASE DEFICIENCY	0.333874419	12.52568286240123
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.505370905857838
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.505370905857838
PSEUDOHYPOALDOSTERONISM, TYPE II	0.333333	12.505370905857838
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857838
CYSTINOSIS, NEPHROPATHIC; CTNS	0.333333	12.505370905857838
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.333333	12.505370905857838
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.32922692000000003	12.351326591706151
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.3215277	12.06248149750366
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.316962989	11.891231113854127
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.31666669999999997	11.880115491217527
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.31044459999999996	11.646686252848275
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.3055556	11.4632697943556
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.30000000000000004	11.254845070117128
INSULIN AUTOIMMUNE SYNDROME	0.27777799999999997	10.421161179623315
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.27370895	10.268506088514782
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.26637682	9.99343279790159
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.26171085	9.818383566395541
PITUITARY APOPLEXY	0.26039801	9.7691308637227
BIOTINIDASE DEFICIENCY	0.25925926	9.726409347644047
LEPTOSPIROSIS	0.25910768	9.72072264959162
SHEEHAN SYNDROME	0.25666667	9.629145351709596
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25508440000000004	9.569784672679283
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.25220834000000003	9.461885973638081
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.2511494	9.42215862150958
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.250541419	9.399349514974329
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.250541419	9.399349514974329
ARGININOSUCCINIC ACIDURIA	0.250541419	9.399349514974329
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.250541419	9.399349514974329
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.25	9.379037558430937
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.379037558430937
PALLISTER-HALL SYNDROME	0.25	9.379037558430937
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.25	9.379037558430937
HYPEREKPLEXIA 1; HKPX1	0.25	9.379037558430937
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.25	9.379037558430937
LACTIC ACIDOSIS, CHRONIC ADULT FORM	0.25	9.379037558430937
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.25	9.379037558430937
LENNOX-GASTAUT SYNDROME	0.24200527	9.079106066672878
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.23944559	8.98307672724262
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.237037	8.892715702951175
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.2272471	8.525436343778045
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.47599193357751
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.22258475900000002	8.350523258381196
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.21743390899999998	8.157283195949818
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.21630151	8.1147999449413
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.21429598	8.03956018016306
AICARDI-GOUTIÈRES SYNDROME	0.209839329	7.872363791707785
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.20704225	7.767428155728191
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.20684932	7.760190164863599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.204462989	7.670664212560206
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.20424821999999998	7.662606906490659
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.200541419	7.523542003288142
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.200541419	7.523542003288142
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.200541419	7.523542003288142
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.503230046744751
ALPHA-METHYLACETOACETIC ACIDURIA	0.2	7.503230046744751
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.503230046744751
BRAIN-LUNG-THYROID SYNDROME	0.2	7.503230046744751
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.2	7.503230046744751
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.2	7.503230046744751
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.2	7.503230046744751
MEDULLARY SPONGE KIDNEY	0.2	7.503230046744751
SHOX-RELATED SHORT STATURE	0.2	7.503230046744751
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.19652777999999999	7.3729657195802085
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.19444430000000001	7.294801570891252
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.19444430000000001	7.294801570891252
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.19444430000000001	7.294801570891252
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.19444430000000001	7.294801570891252
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.19444430000000001	7.294801570891252
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.19444430000000001	7.294801570891252
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.19444430000000001	7.294801570891252
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.19195567	7.201437753935099
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.18939175	7.1052493460278505
JUVENILE MYOCLONIC EPILEPSY	0.1829753	6.864528843860674
UNILATERAL POLYMICROGYRIA	0.18170029999999998	6.816695752312675
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.18159240000000001	6.8126477597024575
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.18074025999999999	6.780678747442291
MYOCLONIC EPILEPSY OF INFANCY	0.18074025999999999	6.780678747442291
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.18016862	6.759233015322685
HEREDITARY FRUCTOSE INTOLERANCE	0.177625119	6.663810649687059
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.173875089	6.523123960826088
KIKUCHI-FUJIMOTO DISEASE	0.17058857000000002	6.399826420276102
CRYPTOSPORIDIOSIS	0.166667	6.252704211004037
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.166667	6.252704211004037
PROPROTEIN CONVERTASE 1/3 DEFICIENCY	0.166667	6.252704211004037
DRACUNCULIASIS	0.166667	6.252704211004037
PRIMARY MYELOFIBROSIS	0.166667	6.252704211004037
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.16574656999999998	6.21817322084441
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.16406003999999996	6.154901107990726
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.98403980433527
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.98403980433527
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.15486339999999998	5.809878580105254
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15211625999999998	5.706816463152182
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	5.687129488155533
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.148148	5.5579426248257064
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.14285699999999998	5.359444673939073
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.359444673939073
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.359444673939073
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.14285699999999998	5.359444673939073
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.13835809999999998	5.190663265652573
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.13624340000000001	5.111327862753319
PROPIONIC ACIDEMIA	0.135778039	5.093869309564402
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.970090811968419
FAMILIAL HYPOALDOSTERONISM	0.1316933	4.940625627574852
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.13007899999999997	4.880063306252551
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.12901942	4.840311943787903
COLCHICINE POISONING	0.12856995	4.82344955974235
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.1270754	4.767379797410539
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.12429182999999999	4.662950967104453
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.12280404	4.607134813948221
PEHO-LIKE SYNDROME; PEHOL	0.12260529999999999	4.5996788542507705
COG8-CDG	0.12224065899999999	4.585998927713394
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.12197001900000001	4.575845556814141
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.12152769999999999	4.559251450758909
GALACTOSEMIA	0.12152769999999999	4.559251450758909
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.12152769999999999	4.559251450758909
TIGLIC ACIDEMIA	0.1213235	4.551590652881184
PYRUVATE CARBOXYLASE DEFICIENCY	0.12109965900000001	4.543193000296717
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.12037025999999999	4.515828757832388
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.43265507760272
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.11796314999999999	4.42552325744329
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.11544029899999998	4.330875600309988
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.11538375899999999	4.328754437175774
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.11369860000000001	4.265533758964064
PEHO SYNDROME; PEHO	0.11165241899999999	4.188768925162671
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.11165241899999999	4.188768925162671
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.11165241899999999	4.188768925162671
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.1114943	4.182836909003866
NEPHROPATHIC INFANTILE CYSTINOSIS	0.11111099999999999	4.168456968619279
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.11111099999999999	4.168456968619279
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.11111099999999999	4.168456968619279
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.11111099999999999	4.168456968619279
SAY-BARBER-MILLER SYNDROME	0.11111099999999999	4.168456968619279
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.11111099999999999	4.168456968619279
RENAL AGENESIS, BILATERAL	0.11111099999999999	4.168456968619279
ENTERIC ANENDOCRINOSIS	0.11111099999999999	4.168456968619279
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.11095811900000001	4.162721462055398
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.1104167	4.142409505512005
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.108354529	4.065044788468377
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.107583669	4.036125088899209
OCULOCEREBRORENAL SYNDROME OF LOWE	0.10739073900000001	4.028887098034617
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.10666667	4.001722816651034
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10621331	3.9847144947810733
GLYCOGEN STORAGE DISEASE 0, LIVER	0.104373539	3.915693369549425
BILATERAL POLYMICROGYRIA	0.10411521000000001	3.9060018599756976
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.10373134	3.891600535385478
AICARDI SYNDROME; AIC	0.1036867	3.8899258144390445
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.10170259999999999	3.8154900207603126
PFAPA SYNDROME	0.10071302000000001	3.7783647888120253
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.100541419	3.7719269799157678
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.100541419	3.7719269799157678
LOWE OCULOCEREBRORENAL SYNDROME	0.100541419	3.7719269799157678
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.1	3.7516150233723753
ARNOLD-CHIARI MALFORMATION TYPE I	0.1	3.7516150233723753
INSULIN-RESISTANCE SYNDROME TYPE B	0.1	3.7516150233723753
X-LINKED ACROGIGANTISM	0.1	3.7516150233723753
NON-FUNCTIONING PARAGANGLIOMA	0.1	3.7516150233723753
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.1	3.7516150233723753
PARAGANGLIOMAS 1	0.1	3.7516150233723753
RABSON-MENDENHALL SYNDROME	0.1	3.7516150233723753
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.1	3.7516150233723753
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.1	3.7516150233723753
PARAGANGLIOMAS 3	0.1	3.7516150233723753
LI-FRAUMENI SYNDROME	0.1	3.7516150233723753
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.1	3.7516150233723753
PARAGANGLIOMAS 4	0.1	3.7516150233723753
CARNEY COMPLEX	0.1	3.7516150233723753
SAY SYNDROME	0.1	3.7516150233723753
RAVINE SYNDROME	0.1	3.7516150233723753
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09840755	3.6918724299326815
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.6811540658109063
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.6811540658109063
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.6811540658109063
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.6811540658109063
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.6811540658109063
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.09784830000000001	3.670891522914472
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.09784830000000001	3.670891522914472
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.09784830000000001	3.670891522914472
HEPATOCELLULAR CARCINOMA	0.09765288000000001	3.663560116835798
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.09764164	3.66313843530717
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.09758363900000001	3.6609624610774647
BETA-KETOTHIOLASE DEFICIENCY	0.094872149	3.5592377948802247
INFANTILE LIVER FAILURE SYNDROME 2	0.09446295900000001	3.543886561366087
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.09382909	3.5201062367335867
CITRULLINEMIA TYPE I	0.09367863900000001	3.5144618944147727
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.09330630000000001	3.5004931685528984
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.09330630000000001	3.5004931685528984
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.09330630000000001	3.5004931685528984
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.09330630000000001	3.5004931685528984
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.09330630000000001	3.5004931685528984
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.09145080000000001	3.430881951794224
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.09145051900000001	3.430871409756008
BETA-THALASSEMIA	0.0909091	3.410559453212616
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.0909091	3.410559453212616
ULNAR-MAMMARY SYNDROME	0.0909091	3.410559453212616
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0909091	3.410559453212616
MACHADO-JOSEPH DISEASE TYPE 3	0.0909091	3.410559453212616
MACHADO-JOSEPH DISEASE TYPE 2	0.0909091	3.410559453212616
SPINOCEREBELLAR ATAXIA TYPE 3	0.0909091	3.410559453212616
MACHADO-JOSEPH DISEASE TYPE 1	0.0909091	3.410559453212616
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.0909091	3.410559453212616
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.09035099899999999	3.389621652251024
CONGENITAL ISOLATED ACTH DEFICIENCY	0.0900384	3.3778941412041124
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.088945789	3.336903582781093
CITRULLINEMIA TYPE II	0.08779628900000001	3.2937787680874284
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.08760605900000001	3.2866420708284676
ACUTE BILIRUBIN ENCEPHALOPATHY	0.08760605900000001	3.2866420708284676
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.08760605900000001	3.2866420708284676
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.08725487000000001	3.273466811544036
HEPATIC VENO-OCCLUSIVE DISEASE	0.08725487000000001	3.273466811544036
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.087167039	3.2701717305528573
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.08635400000000001	3.239669637282981
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.08502421900000001	3.18978137350903
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.08502421900000001	3.18978137350903
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.08502421900000001	3.18978137350903
GLYCEROL KINASE DEFICIENCY; GKD	0.084291489	3.1622921647482727
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.084291489	3.1622921647482727
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.08387471900000001	3.1466565588153648
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.083856129	3.1459591335825188
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.083616229	3.136959009141448
PATENT DUCTUS VENOSUS	0.08333330000000001	3.1263446022719714
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.08333330000000001	3.1263446022719714
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.08113734	3.0439606370047234
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.08113734	3.0439606370047234
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.07904281	2.965381934855682
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.07840243999999999	2.941357717730512
WOLCOTT-RALLISON SYNDROME	0.077796359	2.9186198918807067
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07692310000000001	2.8858585760437556
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07692310000000001	2.8858585760437556
MAPLE SYRUP URINE DISEASE; MSUD	0.076750339	2.879377248413227
LYSOSOMAL ACID LIPASE DEFICIENCY	0.07644366999999999	2.867872208137201
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.07515994000000001	2.8197116005976635
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.07461872	2.799407109768167
GLYCOGEN STORAGE DISEASE IXC	0.07346382	2.7560797078632393
METHYLMALONIC ACIDURIA, CBLA TYPE	0.073458119	2.7558658282907573
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.073243019	2.747796104375483
GLYCOGEN STORAGE DISEASE IXA	0.07308824	2.7419893921584575
METHYLMALONIC ACIDURIA, CBLB TYPE	0.0729167	2.7355538717473644
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07289361	2.7346876238384676
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.07204304	2.7027775119341695
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.07197001900000001	2.700038045127953
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.07197001900000001	2.700038045127953
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.07197001900000001	2.700038045127953
TUBEROUS SCLEROSIS COMPLEX	0.0715302	2.6835377294483065
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.07142860000000001	2.6797260885845606
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.07142860000000001	2.6797260885845606
SILVER-RUSSELL SYNDROME	0.07142860000000001	2.6797260885845606
TEMPLE SYNDROME	0.07142860000000001	2.6797260885845606
%609197 GLUCOCORTICOID DEFICIENCY 3; GCCD3;;FAMILIAL GLUCOCORTICOID DEFICIENCY 3; FGD3;;GLUCOCORTICOID DEFICIENCY 2, FORMERLY; GCCD2, FORMERLY	0.07142860000000001	2.6797260885845606
SCHINZEL-GIEDION SYNDROME	0.07142860000000001	2.6797260885845606
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07077939999999999	2.6553706038528264
HYDROXYKYNURENINURIA	0.07068150000000001	2.6516977727449453
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.07019114	2.6333013533163365
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.069708089	2.615179139429786
SHORT STATURE DUE TO GHSR DEFICIENCY	0.06916667	2.5948671828863934
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.067208119	2.5213898893299835
XP21 MICRODELETION SYNDROME	0.067208119	2.5213898893299835
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.5213898893299835
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.5010779327865906
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.5010779327865906
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.5010779327865906
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.0666667	2.5010779327865906
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.0666667	2.5010779327865906
DIABETES MELLITUS, KETOSIS-PRONE; KPD	0.0666667	2.5010779327865906
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.5010779327865906
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.5010779327865906
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.0666667	2.5010779327865906
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.06665754	2.50073428485045
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.06549017	2.456939056552108
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.06535621900000001	2.451913730712151
ACQUIRED METHEMOGLOBINEMIA	0.064741259	2.42884279896442
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.06433827	2.413724203097882
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.06389694900000001	2.397167538160585
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.06348501	2.3817131727494543
ALAGILLE SYNDROME 1; ALGS1	0.06307467	2.3663187956625484
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.06274507	2.353953472545513
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.06274507	2.353953472545513
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.3484303449081043
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.06240754999999999	2.3412910215186264
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.06096382	2.2871278299416926
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.059887489	2.2467480344444786
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.05979277	2.2431945422104906
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.05979277	2.2431945422104906
VICI SYNDROME; VICIS	0.059364919	2.2271432198168415
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.059140269999999995	2.2187152541829853
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.058958079999999996	2.211880186771903
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.0588235	2.206831263273449
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4	0.0588235	2.206831263273449
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.0588235	2.206831263273449
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.0588235	2.206831263273449
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.1676047517505697
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.056584159	2.1228198098929116
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.0842322359246634
WHITE-SUTTON SYNDROME; WHSUS	0.055555600000000004	2.0842322359246634
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.0842322359246634
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.0842322359246634
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.055555600000000004	2.0842322359246634
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.0842322359246634
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.0842322359246634
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.0842322359246634
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.0842322359246634
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.0842322359246634
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.055555600000000004	2.0842322359246634
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.055229069000000006	2.071982049872695
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.054462989	2.043241677501644
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.054462989	2.043241677501644
KEARNS-SAYRE SYNDROME; KSS	0.053038169	1.9897879163256298
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.052845239	1.9825499254610375
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.052411940000000004	1.9662942150809153
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.920118549534093
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.05073566	1.9034066427671286
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.050541419000000004	1.89611946822958
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.050541419000000004	1.89611946822958
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.050541419000000004	1.89611946822958
KAPOSI SARCOMA	0.0502023	1.8833970288784696
OSTEOPETROSIS AND RELATED DISORDERS	0.04918584	1.845263362811899
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.048710929	1.827446530388251
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.0485313	1.8207075418379175
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.046509089999999996	1.744842007673779
VICI SYNDROME	0.045995919	1.725589807342189
DILATED CARDIOMYOPATHY WITH ATAXIA	0.045795109	1.7180561892137545
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.0454545	1.7052778507987962
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.0454545	1.7052778507987962
ALAGILLE SYNDROME 2	0.0454545	1.7052778507987962
RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	0.0454545	1.7052778507987962
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.04513573	1.6933188275887918
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6854321824866583
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.6040611532757214
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.6040611532757214
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0427032	1.6020596666607516
COG2-CDG	0.041666699999999994	1.5631741769434973
DISTAL MONOSOMY 12Q	0.041666699999999994	1.5631741769434973
HYPOTONIA-CYSTINURIA SYNDROME	0.04152505	1.5578600142628902
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.04152505	1.5578600142628902
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.0414764	1.5560348535540196
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.041459988999999996	1.555419176012534
NEONATAL ADRENOLEUKODYSTROPHY	0.041366299	1.5519042878971367
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.04082488	1.531592331353744
BLAU SYNDROME	0.04076834	1.5294711682195292
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.040763049999999995	1.5292727077847927
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.0407256	1.52786772795854
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.03930035	1.474397834837925
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.474397834837925
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4733380035938226
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4451708779983423
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.038022569	1.4264604108761272
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.038022569	1.4264604108761272
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4212340735032174
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.03767925	1.4135804036940356
SLC39A8-CDG	0.037578419	1.409797612749819
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.037578419	1.409797612749819
MCLEOD SYNDROME; MCLDS	0.037037	1.3894856562064266
CONGENITAL RESPIRATORY-BILIARY FISTULA	0.037037	1.3894856562064266
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.037037	1.3894856562064266
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.037037	1.3894856562064266
LISSENCEPHALY 2; LIS2	0.037037	1.3894856562064266
RHYNS SYNDROME	0.037037	1.3894856562064266
RCAD (RENAL CYSTS AND DIABETES)	0.037037	1.3894856562064266
BUTYRYLCHOLINESTERASE DEFICIENCY	0.037037	1.3894856562064266
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.3894856562064266
CANAVAN DISEASE	0.037037	1.3894856562064266
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.037037	1.3894856562064266
BENIGN SCHWANNOMA	0.037037	1.3894856562064266
FIBROSCLEROSIS, MULTIFOCAL	0.037037	1.3894856562064266
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.3894856562064266
FANCONI ANEMIA	0.037037	1.3894856562064266
TRICHOTHIODYSTROPHY	0.037037	1.3894856562064266
POLAND SYNDROME	0.037037	1.3894856562064266
APOLIPOPROTEIN A-I DEFICIENCY	0.037037	1.3894856562064266
ATRANSFERRINEMIA	0.037037	1.3894856562064266
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.3894856562064266
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.037037	1.3894856562064266
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.037037	1.3894856562064266
SITOSTEROLEMIA	0.037037	1.3894856562064266
MYOCLONUS AND ATAXIA	0.037037	1.3894856562064266
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.037037	1.3894856562064266
BURKITT LYMPHOMA	0.037037	1.3894856562064266
JEUNE SYNDROME	0.037037	1.3894856562064266
16P13.11 MICRODELETION SYNDROME	0.037037	1.3894856562064266
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.3894856562064266
GASTROINTESTINAL STROMAL TUMOR	0.037037	1.3894856562064266
CHRISTIANSON SYNDROME	0.037037	1.3894856562064266
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.03688548	1.3838012091230125
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.036587399	1.372618357545194
MENTAL RETARDATION, X-LINKED 98; MRX98	0.036220379	1.3588491800864126
SLC35A2-CDG	0.03617967	1.357321935126548
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.03604598	1.3523064010018016
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.035714300000000004	1.3398630442922803
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.03566625	1.3380603932735495
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3380603932735495
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3380603932735495
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.03566625	1.3380603932735495
JUVENILE ABSENCE EPILEPSY	0.03566625	1.3380603932735495
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.035437929	1.3294946683360356
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.035024219	1.3139738618228418
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.034820050000000005	1.3063142269457728
ALPERS-HUTTENLOCHER SYNDROME	0.034820050000000005	1.3063142269457728
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457728
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.034627120000000004	1.2990762360811805
BECKWITH-WIEDEMANN SYNDROME	0.0344828	1.2936619052794494
BECKWITH-WIEDEMANN SYNDROME	0.0344828	1.2936619052794494
MODY	0.0344828	1.2936619052794494
MELAS	0.03446908	1.2931471836982427
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	1.2781471013502927
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.034069249999999995	1.2781471013502927
DOORS SYNDROME	0.034069249999999995	1.2781471013502927
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2781471013502927
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.033908069	1.272100210739471
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.0338934	1.2715498863316923
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.03374223	1.2658785699008606
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.03332238	1.2501274142252317
MENINGIOMA	0.03315414	1.24381569710991
GANGLIOCYTOMA	0.03315414	1.24381569710991
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978766
CHROMOSOME 1P36 DELETION SYNDROME	0.032799519	1.2305116823978766
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978766
BENIGN OCCIPITAL EPILEPSY	0.03240334	1.2156485715144303
PEHO SYNDROME	0.0322581	1.2101997258544839
ALG13-CDG	0.0322581	1.2101997258544839
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.0322581	1.2101997258544839
AICARDI SYNDROME	0.0322581	1.2101997258544839
WEST SYNDROME	0.0322581	1.2101997258544839
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.031621939	1.1863334142056483
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.03158369	1.1848984589753582
EPILEPSY, PYRIDOXINE-DEPENDENT	0.03158369	1.1848984589753582
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.031516359	1.1823724590639717
3P25.3 MICRODELETION SYNDROME	0.031226909999999997	1.1715134468949704
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1715134468949704
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.03108052	1.1660214576622558
CHROMOSOME 17Q12 DELETION SYNDROME	0.030948569999999998	1.1610712016389158
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.030533618999999998	1.1455038375832818
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.030533618999999998	1.1455038375832818
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.030462299999999998	1.1428282232647629
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.030195999	1.1328376349413722
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.029981879999999995	1.1248047143694773
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029165418999999998	1.0941742408335011
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.029050318999999998	1.0898561319415996
FUMARASE DEFICIENCY; FMRD	0.02895325	1.086214476754562
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901084
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901084
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.02805236	1.0524165521705027
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.02805236	1.0524165521705027
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.027965509	1.0491582370065538
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.02794327	1.0483239153415058
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.027854260000000002	1.0449846028092022
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0421161179623317
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623317
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.027777800000000002	1.0421161179623317
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.027777800000000002	1.0421161179623317
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0421161179623317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.027777800000000002	1.0421161179623317
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.027777579999999996	1.04210786440928
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.027605868999999998	1.035665928736497
NEUROLEPTIC MALIGNANT SYNDROME	0.02750357	1.0318280640837376
WALDENSTRÖM MACROGLOBULINEMIA	0.02723386	1.0217095832041998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027027	1.0139489923668517
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668517
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668517
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.027027	1.0139489923668517
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668517
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.027027	1.0139489923668517
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.026727849999999997	1.0027260360244332
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.02669998	1.0016804609174195
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.02665294	0.9999157012104252
RIDDLE SYNDROME	0.02665294	0.9999157012104252
MARSILI SYNDROME; MARSIS	0.02665294	0.9999157012104252
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.02665294	0.9999157012104252
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.026517330000000002	0.9948281360772299
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.026304599999999997	0.9868473254380096
AMISH INFANTILE EPILEPSY SYNDROME	0.025385869999999998	0.9523801127337808
SALT-AND-PEPPER SYNDROME	0.025385869999999998	0.9523801127337808
LEISHMANIASIS	0.02519817	0.9453383313349109
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.02519817	0.9453383313349109
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.025021229	0.9387001861964055
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.02500794	0.9382016340759495
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.02500794	0.9382016340759495
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.024667039	0.9254123409451229
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.02430827	0.91195270924192
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.0241153	0.9047132177313183
PRIMARY HYPEROXALURIA TYPE 1	0.0241153	0.9047132177313183
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.024043939	0.9020360277344895
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.024043939	0.9020360277344895
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.02393269	0.897862393537138
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.023866949	0.8953960443046227
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.023866949	0.8953960443046227
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.023866949	0.8953960443046227
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.023866949	0.8953960443046227
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.023866949	0.8953960443046227
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.023866949	0.8953960443046227
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.023866949	0.8953960443046227
ABETAL34V AMYLOIDOSIS	0.02350252	0.881724071191097
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.02340734	0.8781532840118513
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.023347699	0.8759157832957618
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.023325529999999997	0.8750840877612301
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.023325529999999997	0.8750840877612301
ISOLATED COMPLEX I DEFICIENCY	0.023142879999999998	0.8682317629210407
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.02196765	0.8241416576818615
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.02196765	0.8241416576818615
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8241416576818615
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.02196765	0.8241416576818615
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.02196765	0.8241416576818615
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.021818019	0.8185280786062392
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.021818019	0.8185280786062392
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.021818019	0.8185280786062392
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.021818019	0.8185280786062392
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.021818019	0.8185280786062392
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.021818019	0.8185280786062392
KRABBE DISEASE	0.021818019	0.8185280786062392
GITELMAN SYNDROME	0.021818019	0.8185280786062392
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.021546359	0.8083364412337458
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.021356129	0.8011997439747846
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.02129822	0.7990272212308999
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0212766	0.7982161220628466
FAMILIAL MEDITERRANEAN FEVER; FMF	0.0212766	0.7982161220628466
IMMUNODEFICIENCY 61; IMD61	0.0212766	0.7982161220628466
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.0212766	0.7982161220628466
H SYNDROME	0.0212766	0.7982161220628466
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.0212766	0.7982161220628466
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.0212766	0.7982161220628466
STÜVE-WIEDEMANN SYNDROME	0.0212766	0.7982161220628466
NAKAJO-NISHIMURA SYNDROME	0.0212766	0.7982161220628466
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0212766	0.7982161220628466
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	0.0212766	0.7982161220628466
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.0212766	0.7982161220628466
AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.0212766	0.7982161220628466
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.0212766	0.7982161220628466
CAROLI DISEASE, ISOLATED	0.0212766	0.7982161220628466
DOHLE BODIES AND LEUKEMIA	0.0212766	0.7982161220628466
MAJEED SYNDROME	0.0212766	0.7982161220628466
IMMUNODEFICIENCY 9; IMD9	0.0212766	0.7982161220628466
YAO SYNDROME	0.0212766	0.7982161220628466
STUVE-WIEDEMANN SYNDROME	0.0212766	0.7982161220628466
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.02120304	0.7954564340516539
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.02120304	0.7954564340516539
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.02120304	0.7954564340516539
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.02120304	0.7954564340516539
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.02120304	0.7954564340516539
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.02120304	0.7954564340516539
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.02120304	0.7954564340516539
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.02118759	0.7948768095305428
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.02118759	0.7948768095305428
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.021099659	0.7915779769243413
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.021099659	0.7915779769243413
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	0.7889376277870421
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	0.7889376277870421
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	0.7889376277870421
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	0.7889376277870421
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	0.7889376277870421
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.020928259999999997	0.7851477462904313
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.020928259999999997	0.7851477462904313
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.020928259999999997	0.7851477462904313
CADASIL	0.020743349	0.7782105974345633
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.020740849999999998	0.7781168445751292
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751292
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.020740849999999998	0.7781168445751292
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751292
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.02055824	0.7712660203809489
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.020547919999999997	0.7708788537105369
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.020392079	0.7650322993419632
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.020392079	0.7650322993419632
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.020365269999999998	0.7640265288703472
GAUCHER DISEASE	0.020032849999999998	0.7515554102096528
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.019684119	0.7384723656224961
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.019616359	0.735930271282659
SNEDDON SYNDROME	0.019616359	0.735930271282659
ABETA AMYLOIDOSIS, DUTCH TYPE	0.019616359	0.735930271282659
ENCEPHALITIS LETHARGICA	0.019083059000000003	0.7159229083630142
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.01907494	0.7156183147392664
POLYCYTHEMIA VERA	0.01907494	0.7156183147392664
SECONDARY POLYCYTHEMIA	0.01907494	0.7156183147392664
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.018968	0.711606337633272
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.018968	0.711606337633272
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.018968	0.711606337633272
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.018968	0.711606337633272
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.018968	0.711606337633272
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.018885039	0.7084939602937321
GAUCHER DISEASE TYPE 2	0.01869322	0.7012976498720495
GAUCHER DISEASE TYPE 3	0.01869322	0.7012976498720495
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.01869322	0.7012976498720495
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.01853655	0.6954199946149319
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.01853655	0.6954199946149319
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149319
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.01853655	0.6954199946149319
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.018000369000000002	0.6753045476664639
HISTIOCYTOID CARDIOMYOPATHY	0.017981679	0.6746033708185954
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.017813139999999998	0.6682804363743537
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.017813139999999998	0.6682804363743537
LIVER FAILURE, INFANTILE, TRANSIENT	0.017813139999999998	0.6682804363743537
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.017813139999999998	0.6682804363743537
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.017807439	0.6680665568018714
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.017807439	0.6680665568018714
GLYCOGEN STORAGE DISEASE IA	0.01763049	0.6614281115341643
GLYCOGEN STORAGE DISEASE IB	0.01763049	0.6614281115341643
NAVAJO NEUROHEPATOPATHY	0.01763049	0.6614281115341643
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.017628289000000002	0.6613455384874999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.01748648	0.6560254107390056
AMISH LETHAL MICROCEPHALY	0.01745895	0.6549925911230713
PEARSON SYNDROME	0.01745895	0.6549925911230713
HEMORRHAGIC FEVER-RENAL SYNDROME	0.01745683	0.6549130568845757
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.017292409	0.6487446139469967
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.01726602	0.6477546002584789
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397247
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397247
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397247
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397247
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397247
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6468309526397247
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397247
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397247
RHEUMATOID ARTHRITIS	0.0172414	0.6468309526397247
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397247
MOSAIC TRISOMY 15	0.0172414	0.6468309526397247
MOTION SICKNESS	0.0172414	0.6468309526397247
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397247
ERYTHERMALGIA, PRIMARY	0.0172414	0.6468309526397247
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397247
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6468309526397247
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397247
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397247
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397247
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397247
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397247
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397247
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397247
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397247
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397247
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397247
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6468309526397247
CERVICAL RIB	0.0172414	0.6468309526397247
TRANSSEXUALITY	0.0172414	0.6468309526397247
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6468309526397247
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6468309526397247
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397247
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397247
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397247
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397247
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397247
DIASTEMATOMYELIA	0.0172414	0.6468309526397247
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6468309526397247
THUMBS, CONGENITAL CLASPED	0.0172414	0.6468309526397247
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397247
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397247
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6468309526397247
PALMOMENTAL REFLEX	0.0172414	0.6468309526397247
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397247
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397247
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6468309526397247
SICKLE CELL ANEMIA	0.0172414	0.6468309526397247
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.017194659	0.6450774102616502
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.017194659	0.6450774102616502
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.017099479	0.6415066230824044
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.017099479	0.6415066230824044
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.017099479	0.6415066230824044
PRIMARY SCLEROSING CHOLANGITIS	0.01708687	0.6410335819441073
RIBOFLAVIN DEFICIENCY	0.01708337	0.6409022754182893
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.017017629	0.638435926185774
ETHYLMALONIC ENCEPHALOPATHY	0.017017629	0.638435926185774
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.017017629	0.638435926185774
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.017017629	0.638435926185774
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.016649999	0.6246438638753502
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.016476209999999998	0.6181239696423815
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.016476209999999998	0.6181239696423815
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.016476209999999998	0.6181239696423815
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965499
PERMANENT NEONATAL DIABETES MELLITUS	0.016301509999999998	0.6115698981965499
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6115698981965499
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.016301509999999998	0.6115698981965499
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965499
TRANSIENT NEONATAL DIABETES MELLITUS	0.016301509999999998	0.6115698981965499
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965499
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.01610858	0.6043319073319577
PYRIDOXINE-DEPENDENT EPILEPSY	0.01528218	0.5733285607788084
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.015180260000000001	0.5695049147469873
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.015043649	0.564379795947408
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5599435486984203
HAREL-YOON SYNDROME; HAYOS	0.014925399999999998	0.5599435486984203
MENTAL RETARDATION, X-LINKED 41	0.014925399999999998	0.5599435486984203
NIEMANN-PICK DISEASE TYPE B	0.014925399999999998	0.5599435486984203
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5599435486984203
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5599435486984203
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.014925399999999998	0.5599435486984203
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5599435486984203
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.014925399999999998	0.5599435486984203
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.014925399999999998	0.5599435486984203
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.014925399999999998	0.5599435486984203
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.014432989	0.5414701836456823
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.014432989	0.5414701836456823
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.014432989	0.5414701836456823
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.014432989	0.5414701836456823
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.014432988999999999	0.5414701836456822
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.014432988999999999	0.5414701836456822
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.014432988999999999	0.5414701836456822
LEIGH SYNDROME; LS	0.014432988999999999	0.5414701836456822
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.014432988999999999	0.5414701836456822
PRIMARY HYPEROXALURIA	0.01433827	0.5379166914116942
2P21 MICRODELETION SYNDROME	0.014250339	0.5346178588054927
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.014250339	0.5346178588054927
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.014250338999999999	0.5346178588054926
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.014240018999999998	0.5342306921350806
CITRULLINEMIA, CLASSIC	0.014240018999999998	0.5342306921350806
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.014240018999999998	0.5342306921350806
CEDNIK SYNDROME	0.014240018999999998	0.5342306921350806
PRADER-WILLI SYNDROME	0.014240018999999998	0.5342306921350806
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.014240018999999998	0.5342306921350806
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.014240018999999998	0.5342306921350806
STURGE-WEBER SYNDROME	0.014240018999999998	0.5342306921350806
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.014240018999999998	0.5342306921350806
PITT-HOPKINS-LIKE SYNDROME	0.014171729	0.5316687142356196
MALIGNANT HYPERTHERMIA OF ANESTHESIA	0.01414804	0.5307799941527329
IMMUNOGLOBULIN A VASCULITIS	0.014076679000000002	0.5281028041559043
TAKAYASU ARTERITIS	0.014076679000000002	0.5281028041559043
VIRAL HEMORRHAGIC FEVER	0.014076679000000002	0.5281028041559043
BEHÇET DISEASE	0.014076679000000002	0.5281028041559043
RABIES	0.014076679	0.5281028041559042
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.013891569999999999	0.5211582271022898
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.013891569999999999	0.5211582271022898
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.013891569999999999	0.5211582271022898
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.013891569999999999	0.5211582271022898
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.013891569999999999	0.5211582271022898
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.013891569999999999	0.5211582271022898
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.013891569999999999	0.5211582271022898
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.013891569999999999	0.5211582271022898
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.01370892	0.5143059022621002
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.013706719	0.5142233292154358
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.013706719	0.5142233292154358
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.013698599999999998	0.5139187355916881
WILLIAMS SYNDROME	0.013698599999999998	0.5139187355916881
SICKLE CELL ANEMIA	0.013698599999999998	0.5139187355916881
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.013698599999999998	0.5139187355916881
STROKE, ISCHEMIC	0.013698599999999998	0.5139187355916881
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.013698599999999998	0.5139187355916881
19P13.3 MICRODUPLICATION SYNDROME	0.013698599999999998	0.5139187355916881
EISENMENGER SYNDROME	0.013698599999999998	0.5139187355916881
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.013698599999999998	0.5139187355916881
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.013698599999999998	0.5139187355916881
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.013698599999999998	0.5139187355916881
ABETA AMYLOIDOSIS, IOWA TYPE	0.013698599999999998	0.5139187355916881
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.013698599999999998	0.5139187355916881
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.013698599999999998	0.5139187355916881
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.5139187355916881
AYMÉ-GRIPP SYNDROME	0.013698599999999998	0.5139187355916881
ACYS AMYLOIDOSIS	0.013698599999999998	0.5139187355916881
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.013698599999999998	0.5139187355916881
APPARENT MINERALOCORTICOID EXCESS	0.013698599999999998	0.5139187355916881
AMYLOIDOSIS VI	0.013698599999999998	0.5139187355916881
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.5139187355916881
WOLFF-PARKINSON-WHITE SYNDROME	0.013698599999999998	0.5139187355916881
AORTA COARCTATION	0.013698599999999998	0.5139187355916881
WILLIAMS-BEUREN SYNDROME; WBS	0.013698599999999998	0.5139187355916881
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.5139187355916881
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.013698599999999998	0.5139187355916881
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.013698599999999998	0.5139187355916881
PSEUDOXANTHOMA ELASTICUM; PXE	0.013698599999999998	0.5139187355916881
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.013698599999999998	0.5139187355916881
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.5139187355916881
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.5139187355916881
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.013698599999999998	0.5139187355916881
DERMOGRAPHISM, FAMILIAL	0.013698599999999998	0.5139187355916881
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.013698599999999998	0.5139187355916881
CARDIOMYOPATHY, DILATED, 1E	0.013698599999999998	0.5139187355916881
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.013698599999999998	0.5139187355916881
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.013698599999999998	0.5139187355916881
ANEURYSM OF SINUS OF VALSALVA	0.013698599999999998	0.5139187355916881
ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	0.013698599999999998	0.5139187355916881
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.5139187355916881
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5139187355916881
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.013698599999999998	0.5139187355916881
ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	0.013698599999999998	0.5139187355916881
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.5139187355916881
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.013698599999999998	0.5139187355916881
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.013698599999999998	0.5139187355916881
FAMILIAL AORTIC DISSECTION	0.013698599999999998	0.5139187355916881
MOYAMOYA DISEASE WITH EARLY-ONSET ACHALASIA	0.013698599999999998	0.5139187355916881
HEPARIN-INDUCED THROMBOCYTOPENIA	0.013698599999999998	0.5139187355916881
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.5139187355916881
KAWASAKI DISEASE	0.01353526	0.5077908476125117
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.01353526	0.5077908476125117
RHEUMATIC FEVER	0.01353526	0.5077908476125117
CINCA SYNDROME	0.01353526	0.5077908476125117
LEGIONELLOSIS	0.01353526	0.5077908476125117
CLASSIC HODGKIN LYMPHOMA	0.01353526	0.5077908476125117
KERION CELSI	0.01353526	0.5077908476125117
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.01353526	0.5077908476125117
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.013355530000000001	0.5010480699310046
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.013180830000000001	0.49449399848517306
LETTERER-SIWE DISEASE	0.0131653	0.4939113726720432
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.01302925	0.4888073004327451
MARBURG HEMORRHAGIC FEVER	0.01302925	0.4888073004327451
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.01302925	0.4888073004327451
RELAPSING FEVER	0.01302925	0.4888073004327451
KRABBE DISEASE	0.0129906	0.48735730122621174
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.01241859	0.46589768813101945
HYPERPROLINEMIA, TYPE I	0.012035718999999999	0.4515338421748833
INFANTILE LIVER FAILURE SYNDROME 1	0.011505239	0.43163227479889765
PSEUDO-TORCH SYNDROME 2	0.011505238999999999	0.43163227479889754
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.011494299999999999	0.43122188563149083
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.011494299999999999	0.43122188563149083
WRINKLY SKIN SYNDROME	0.011494299999999999	0.43122188563149083
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.011494299999999999	0.43122188563149083
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.43122188563149083
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.011494299999999999	0.43122188563149083
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.43122188563149083
PERLMAN SYNDROME	0.011494299999999999	0.43122188563149083
DESMOSTEROLOSIS	0.011494299999999999	0.43122188563149083
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.011494299999999999	0.43122188563149083
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.011494299999999999	0.43122188563149083
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.011494299999999999	0.43122188563149083
RING CHROMOSOME 14 SYNDROME	0.011494299999999999	0.43122188563149083
BETA-UREIDOPROPIONASE DEFICIENCY	0.011494299999999999	0.43122188563149083
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.011494299999999999	0.43122188563149083
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.011494299999999999	0.43122188563149083
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.011494299999999999	0.43122188563149083
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.011494299999999999	0.43122188563149083
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.43122188563149083
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.011312309	0.4243942839343052
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.011129659	0.41754195909411557
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.011129659	0.41754195909411557
CONGENITAL DISORDER OF GLYCOSYLATION	0.011129659	0.41754195909411557
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.011129659	0.41754195909411557
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.010963819999999999	0.41132031825550514
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.010963819999999999	0.41132031825550514
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.010963819999999999	0.41132031825550514
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.010963819999999999	0.41132031825550514
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.010958119	0.4111064386830227
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.010958119	0.4111064386830227
SUDDEN CARDIAC FAILURE, INFANTILE	0.010958119	0.4111064386830227
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.010958119	0.4111064386830227
ISOLATED GLYCEROL KINASE DEFICIENCY	0.010958119	0.4111064386830227
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.010958119	0.4111064386830227
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.010958119	0.4111064386830227
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.010958119	0.4111064386830227
ISOVALERIC ACIDEMIA	0.010958119	0.4111064386830227
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01083013	0.40630478413075866
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.01077359	0.4041836209965438
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.01077359	0.4041836209965438
TYROSINEMIA, TYPE I; TYRSN1	0.01058824	0.39723000255072316
GLYCOGEN STORAGE DISEASE VI	0.01058824	0.39723000255072316
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.01058824	0.39723000255072316
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.01058824	0.39723000255072316
MICROVILLUS INCLUSION DISEASE	0.010416700000000001	0.39079448213963025
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.010416700000000001	0.39079448213963025
HAWKINSINURIA	0.010416700000000001	0.39079448213963025
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.010416700000000001	0.39079448213963025
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.010416700000000001	0.39079448213963025
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.010416700000000001	0.39079448213963025
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.010416700000000001	0.39079448213963025
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.010416700000000001	0.39079448213963025
LACTASE DEFICIENCY, CONGENITAL	0.010416700000000001	0.39079448213963025
HAWKINSINURIA	0.010416700000000001	0.39079448213963025
BENIGN FAMILIAL INFANTILE EPILEPSY	0.010345339	0.38811729214280144
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.010345339	0.38811729214280144
LYNCH SYNDROME	0.010345339	0.38811729214280144
EPISODIC ATAXIA, TYPE 6	0.010345339	0.38811729214280144
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.010345339	0.38811729214280144
MALAN OVERGROWTH SYNDROME	0.010345339	0.38811729214280144
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.010345339	0.38811729214280144
FAMILIAL COLORECTAL CANCER TYPE X	0.010345339	0.38811729214280144
SYSTEMIC SCLEROSIS	0.010345339	0.38811729214280144
ATYPICAL TERATOID RHABDOID TUMOR	0.010345339	0.38811729214280144
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.010345339	0.38811729214280144
EPENDYMOMA	0.010345339	0.38811729214280144
MALIGNANT ATROPHIC PAPULOSIS	0.010345339	0.38811729214280144
CYCLIC VOMITING SYNDROME	0.010345339	0.38811729214280144
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.010345339	0.38811729214280144
SNEDDON SYNDROME	0.010345339	0.38811729214280144
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.010345339	0.38811729214280144
DISTAL 16P11.2 MICRODELETION SYNDROME	0.010345339	0.38811729214280144
SUBEPENDYMOMA	0.010345339	0.38811729214280144
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.010345339	0.38811729214280144
SAETHRE-CHOTZEN SYNDROME	0.010345339	0.38811729214280144
NORRIE DISEASE	0.010345339	0.38811729214280144
BERNARD-SOULIER SYNDROME	0.010345339	0.38811729214280144
PHACE ASSOCIATION	0.010345339	0.38811729214280144
PULMONARY ARTERIOVENOUS MALFORMATION	0.010345339	0.38811729214280144
EPISODIC ATAXIA TYPE 6	0.010345339	0.38811729214280144
HARTNUP DISEASE	0.010345339	0.38811729214280144
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.010250159	0.3845465049635556
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.010250159	0.3845465049635556
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.010250159	0.3845465049635556
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.010250159	0.3845465049635556
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.010250159	0.3845465049635556
RAYNAUD-CLAES SYNDROME; MRXSRC	0.010250159	0.3845465049635556
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.010250159	0.3845465049635556
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.010250159	0.3845465049635556
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.010250159	0.3845465049635556
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.010250159	0.3845465049635556
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.010250159	0.3845465049635556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.010250159	0.3845465049635556
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.010250159	0.3845465049635556
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.010250159	0.3845465049635556
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.009975379	0.37423781720233296
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.009975379	0.37423781720233296
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.009975379	0.37423781720233296
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.009975379	0.37423781720233296
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.009975379	0.37423781720233296
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.009975379	0.37423781720233296
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.009975379	0.37423781720233296
FADD-RELATED IMMUNODEFICIENCY	0.009975379	0.37423781720233296
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.009975379	0.37423781720233296
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.009975379	0.37423781720233296
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.009975379	0.37423781720233296
HYPEREKPLEXIA 4; HKPX4	0.009975379	0.37423781720233296
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.009975379	0.37423781720233296
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.009975379	0.37423781720233296
GLUTAMINE DEFICIENCY, CONGENITAL	0.009975379	0.37423781720233296
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.009975379	0.37423781720233296
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.009975379	0.37423781720233296
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.009975379	0.37423781720233296
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.009975379	0.37423781720233296
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.009975379	0.37423781720233296
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.009975379	0.37423781720233296
GLYCINE ENCEPHALOPATHY; GCE	0.009975379	0.37423781720233296
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.009975379	0.37423781720233296
PITT-HOPKINS SYNDROME	0.009975379	0.37423781720233296
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.009975379	0.37423781720233296
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.009975379	0.37423781720233296
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.009839328999999999	0.36913374496303486
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00980392	0.367805335599409
PEROXISOME BIOGENESIS DISORDER 14B	0.00980392	0.367805335599409
NEUROFIBROMATOSIS TYPE 2	0.00980392	0.367805335599409
SPINOCEREBELLAR ATAXIA TYPE 36	0.00980392	0.367805335599409
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.00980392	0.367805335599409
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.00980392	0.367805335599409
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.00980392	0.367805335599409
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00980392	0.367805335599409
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.00980392	0.367805335599409
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00980392	0.367805335599409
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00980392	0.367805335599409
EPISODIC ATAXIA, TYPE 2	0.00980392	0.367805335599409
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.00980392	0.367805335599409
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00980392	0.367805335599409
FAMILIAL PAROXYSMAL ATAXIA	0.00980392	0.367805335599409
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00980392	0.367805335599409
ACROMEGALY	0.00980392	0.367805335599409
EPISODIC ATAXIA TYPE 7	0.00980392	0.367805335599409
BLACKFAN-DIAMOND ANEMIA	0.00980392	0.367805335599409
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00980392	0.367805335599409
STORMORKEN SYNDROME; STRMK	0.00980392	0.367805335599409
VON HIPPEL-LINDAU DISEASE	0.00980392	0.367805335599409
SOMATOMAMMOTROPINOMA	0.00980392	0.367805335599409
FAMILIAL CERVICAL ARTERY DISSECTION	0.00980392	0.367805335599409
CLASSICAL EHLERS-DANLOS SYNDROME	0.00980392	0.367805335599409
ARACHNOIDITIS	0.00980392	0.367805335599409
VASCULAR EHLERS-DANLOS SYNDROME	0.00980392	0.367805335599409
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.00980392	0.367805335599409
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.3676837457565014
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.009800679	0.3676837457565014
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.00970874	0.3642345484201631
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00970874	0.3642345484201631
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00970874	0.3642345484201631
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00970874	0.3642345484201631
LASSA FEVER	0.009649099	0.36199704770407354
NOCARDIOSIS	0.009649099	0.36199704770407354
RIFT VALLEY FEVER	0.009649099	0.36199704770407354
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.009649099	0.36199704770407354
POSTENCEPHALITIC PARKINSONISM	0.009649099	0.36199704770407354
LUJO HEMORRHAGIC FEVER	0.009649099	0.36199704770407354
NIPAH VIRUS DISEASE	0.009649099	0.36199704770407354
CRYPTOCOCCOSIS	0.009649099	0.36199704770407354
SCRUB TYPHUS	0.009649099	0.36199704770407354
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.009649099	0.36199704770407354
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.009649099	0.36199704770407354
GRANULOMATOSIS WITH POLYANGIITIS	0.009649099	0.36199704770407354
ROSAÏ-DORFMAN DISEASE	0.009649099	0.36199704770407354
CENTRAL DIABETES INSIPIDUS	0.009649099	0.36199704770407354
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.00943396	0.3539258606589405
IMMUNODEFICIENCY 44	0.00943396	0.3539258606589405
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00943396	0.3539258606589405
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00943396	0.3539258606589405
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.00943396	0.3539258606589405
MEDULLOBLASTOMA	0.00929791	0.34882178841964234
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.00929791	0.34882178841964234
HELLP SYNDROME	0.00929791	0.34882178841964234
PREECLAMPSIA	0.00929791	0.34882178841964234
MERRF	0.00925926	0.34737178921310896
XQ12-Q13.3 DUPLICATION SYNDROME	0.00925926	0.34737178921310896
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.34737178921310896
PAINE SYNDROME	0.00925926	0.34737178921310896
CARNOSINASE DEFICIENCY	0.00925926	0.34737178921310896
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.34737178921310896
CARNOSINEMIA	0.00925926	0.34737178921310896
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.00925926	0.34737178921310896
MICROHYDRANENCEPHALY; MHAC	0.00925926	0.34737178921310896
ROIFMAN-CHITAYAT SYNDROME	0.00925926	0.34737178921310896
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.34737178921310896
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.34737178921310896
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.34737178921310896
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.34737178921310896
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.00925926	0.34737178921310896
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.34737178921310896
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.34737178921310896
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.34737178921310896
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.34737178921310896
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.34737178921310896
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.00925926	0.34737178921310896
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.00925926	0.34737178921310896
HYDROXYLYSINURIA	0.00925926	0.34737178921310896
X-LINKED ADRENOLEUKODYSTROPHY	0.00916422	0.34380625429489586
POSTORGASMIC ILLNESS SYNDROME	0.00910768	0.34168509116068113
TYPHOID	0.00910768	0.34168509116068113
YELLOW FEVER	0.00910768	0.34168509116068113
PAROXYSMAL COLD HEMOGLOBINURIA	0.00910768	0.34168509116068113
HODGKIN LYMPHOMA	0.00910768	0.34168509116068113
MAJEED SYNDROME	0.00910768	0.34168509116068113
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.00910768	0.34168509116068113
BABESIOSIS	0.00910768	0.34168509116068113
RHABDOID TUMOR	0.00910768	0.34168509116068113
DENGUE FEVER	0.00910768	0.34168509116068113
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.00910768	0.34168509116068113
LYME DISEASE	0.00910768	0.34168509116068113
MALARIA	0.00910768	0.34168509116068113
HUGHES-STOVIN SYNDROME	0.00910768	0.34168509116068113
PONTIAC FEVER	0.00910768	0.34168509116068113
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.00910768	0.34168509116068113
PLAGUE	0.00910768	0.34168509116068113
AMERICAN TRYPANOSOMIASIS	0.00910768	0.34168509116068113
AUTOIMMUNE HEMOLYTIC ANEMIA	0.00910768	0.34168509116068113
FAMILIAL COLD URTICARIA	0.00910768	0.34168509116068113
GIANT CELL ARTERITIS	0.00910768	0.34168509116068113
RAT-BITE FEVER	0.00910768	0.34168509116068113
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.008194329	0.3074196778285593
RECURRENT ACUTE PANCREATITIS	0.008194329	0.3074196778285593
PMM2-CDG	0.008194329	0.3074196778285593
STEVENS-JOHNSON SYNDROME	0.007652910000000001	0.2871077212851668
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.007652910000000001	0.2871077212851668
SEVERE COMBINED IMMUNODEFICIENCY DUE TO COMPLETE RAG1/2 DEFICIENCY	0.007652910000000001	0.2871077212851668
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.007652910000000001	0.2871077212851668
BETA-THALASSEMIA MAJOR	0.007652910000000001	0.2871077212851668
ADULT-ONSET STILL DISEASE	0.007652910000000001	0.2871077212851668
BUDD-CHIARI SYNDROME	0.007652910000000001	0.2871077212851668
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.0075836689999999995	0.28451006552683356
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.0075836689999999995	0.28451006552683356
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.0075836689999999995	0.28451006552683356
3-HYDROXYISOBUTYRIC ACIDURIA	0.0075836689999999995	0.28451006552683356
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.28451006552683356
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.0075836689999999995	0.28451006552683356
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.0075836689999999995	0.28451006552683356
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.0075836689999999995	0.28451006552683356
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.0075836689999999995	0.28451006552683356
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.0075836689999999995	0.28451006552683356
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.0075836689999999995	0.28451006552683356
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.0075836689999999995	0.28451006552683356
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0075836689999999995	0.28451006552683356
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.28451006552683356
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.0075836689999999995	0.28451006552683356
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0075836689999999995	0.28451006552683356
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.007390739	0.27727207466224124
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.007390739	0.27727207466224124
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.007390739	0.27727207466224124
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.007390739	0.27727207466224124
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.007390739	0.27727207466224124
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.007390739	0.27727207466224124
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.007390739	0.27727207466224124
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.007390739	0.27727207466224124
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.007390739	0.27727207466224124
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.007390739	0.27727207466224124
PERRAULT SYNDROME 5; PRLTS5	0.007390739	0.27727207466224124
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.007390739	0.27727207466224124
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.007208089000000001	0.27041974982205164
HOLOPROSENCEPHALY	0.007208089000000001	0.27041974982205164
ENDOCARDIAL FIBROELASTOSIS	0.007208089000000001	0.27041974982205164
GALACTOSEMIA	0.007208089000000001	0.27041974982205164
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.007208089000000001	0.27041974982205164
MEHMO SYNDROME; MEHMO	0.007208089000000001	0.27041974982205164
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.007208089000000001	0.27041974982205164
HOLOPROSENCEPHALY 1; HPE1	0.007208089000000001	0.27041974982205164
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.007208089000000001	0.27041974982205164
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.007208089000000001	0.27041974982205164
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.007208089000000001	0.27041974982205164
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.007208089000000001	0.27041974982205164
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.007208089000000001	0.27041974982205164
PITUITARY STALK INTERRUPTION SYNDROME	0.007208089000000001	0.27041974982205164
MENKES DISEASE	0.007208089000000001	0.27041974982205164
SMITH-KINGSMORE SYNDROME; SKS	0.007208089000000001	0.27041974982205164
HYPOADRENOCORTICISM, FAMILIAL	0.007208089000000001	0.27041974982205164
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.007208089000000001	0.27041974982205164
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.007208089000000001	0.27041974982205164
SOTOS SYNDROME	0.007208089000000001	0.27041974982205164
MIRAGE SYNDROME; MIRAGE	0.007208089000000001	0.27041974982205164
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.007208089000000001	0.27041974982205164
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.007208089000000001	0.27041974982205164
FRUCTOSE AND GALACTOSE INTOLERANCE	0.007208089000000001	0.27041974982205164
OCULODENTODIGITAL DYSPLASIA	0.007208089000000001	0.27041974982205164
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.007208089000000001	0.27041974982205164
TENORIO SYNDROME; TNORS	0.007208089000000001	0.27041974982205164
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.007208089000000001	0.27041974982205164
TIMOTHY SYNDROME; TS	0.007208089000000001	0.27041974982205164
SHASHI-PENA SYNDROME; SHAPNS	0.007208089000000001	0.27041974982205164
VISCERAL STEATOSIS, CONGENITAL	0.007208089000000001	0.27041974982205164
SIMPSON-GOLABI-BEHMEL SYNDROME	0.007208089000000001	0.27041974982205164
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00704225	0.26419810898344104
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00704225	0.26419810898344104
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.26419810898344104
OLIVER SYNDROME	0.00704225	0.26419810898344104
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.00704225	0.26419810898344104
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00704225	0.26419810898344104
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 4; CEMCOX4	0.00704225	0.26419810898344104
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00704225	0.26419810898344104
1Q44 MICRODELETION SYNDROME	0.00704225	0.26419810898344104
MYOPATHY, MITOCHONDRIAL, LETHAL INFANTILE	0.00704225	0.26419810898344104
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.26419810898344104
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.00704225	0.26419810898344104
SUCCINIC ACIDEMIA	0.00704225	0.26419810898344104
HALLERMANN-STREIFF SYNDROME; HSS	0.00704225	0.26419810898344104
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00704225	0.26419810898344104
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.26419810898344104
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.26419810898344104
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00704225	0.26419810898344104
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.26419810898344104
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.00704225	0.26419810898344104
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00704225	0.26419810898344104
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00704225	0.26419810898344104
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00704225	0.26419810898344104
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.00704225	0.26419810898344104
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.00704225	0.26419810898344104
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.26419810898344104
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.00704225	0.26419810898344104
OROFACIODIGITAL SYNDROME TYPE 2	0.00704225	0.26419810898344104
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.00704225	0.26419810898344104
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00704225	0.26419810898344104
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00704225	0.26419810898344104
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.00704225	0.26419810898344104
SARCOSINEMIA	0.00704225	0.26419810898344104
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.00704225	0.26419810898344104
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26419810898344104
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00704225	0.26419810898344104
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.00704225	0.26419810898344104
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26419810898344104
GRACILE SYNDROME	0.00704225	0.26419810898344104
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.00704225	0.26419810898344104
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26419810898344104
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26419810898344104
X SMALL RINGS	0.00704225	0.26419810898344104
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26419810898344104
PHENFORMIN 4-HYDROXYLATION	0.00704225	0.26419810898344104
W SYNDROME	0.00704225	0.26419810898344104
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00704225	0.26419810898344104
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26419810898344104
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.00704225	0.26419810898344104
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.00704225	0.26419810898344104
PELGER-HUET ANOMALY; PHA	0.00704225	0.26419810898344104
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26419810898344104
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00684932	0.2569601181188487
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.00684932	0.2569601181188487
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00684932	0.2569601181188487
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00684932	0.2569601181188487
GLYCOGEN STORAGE DISEASE XI; GSD11	0.00684932	0.2569601181188487
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00684932	0.2569601181188487
LEBER OPTIC ATROPHY AND DYSTONIA	0.00684932	0.2569601181188487
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.00684932	0.2569601181188487
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00684932	0.2569601181188487
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.00684932	0.2569601181188487
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.00684932	0.2569601181188487
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.00684932	0.2569601181188487
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.00684932	0.2569601181188487
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.00684932	0.2569601181188487
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.00684932	0.2569601181188487
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00684932	0.2569601181188487
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.00684932	0.2569601181188487
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.00684932	0.2569601181188487
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.00684932	0.2569601181188487
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00684932	0.2569601181188487
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00684932	0.2569601181188487
GLYCOGEN STORAGE DISEASE DUE TO LACTATE DEHYDROGENASE DEFICIENCY	0.00684932	0.2569601181188487
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00684932	0.2569601181188487
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00684932	0.2569601181188487
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00684932	0.2569601181188487
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.00684932	0.2569601181188487
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.00684932	0.2569601181188487
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.00666667	0.2501077932786591
POST-TRAUMATIC PITUITARY DEFICIENCY	0.00666667	0.2501077932786591
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00666667	0.2501077932786591
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00666667	0.2501077932786591
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.00666667	0.2501077932786591
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00666667	0.2501077932786591
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00666667	0.2501077932786591
SHORT STATURE DUE TO PARTIAL GHR DEFICIENCY	0.00666667	0.2501077932786591
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00666667	0.2501077932786591
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00666667	0.2501077932786591
ORTHOSTATIC HYPOTENSION 2; ORTHYP2	0.00666667	0.2501077932786591
CLASSIC GALACTOSEMIA	0.00666667	0.2501077932786591
COSTELLO SYNDROME; CSTLO	0.00666667	0.2501077932786591
CONGENITAL ISOLATED HYPERINSULINISM	0.00666667	0.2501077932786591
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.00666667	0.2501077932786591
PROPIONIC ACIDEMIA	0.00666667	0.2501077932786591
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.00666667	0.2501077932786591
GLYCOGEN STORAGE DISEASE DUE TO LIVER GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00666667	0.2501077932786591
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.00666667	0.2501077932786591
LARON SYNDROME	0.00666667	0.2501077932786591
PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL	0.00666667	0.2501077932786591
NEONATAL HEMOCHROMATOSIS	0.00666667	0.2501077932786591
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.00666667	0.2501077932786591
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.00666667	0.2501077932786591
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00666667	0.2501077932786591
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.00666667	0.2501077932786591
PANHYPOPITUITARISM	0.00666667	0.2501077932786591
ORNITHINE TRANSCARBAMYLASE DEFICIENCY	0.00666667	0.2501077932786591
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00666667	0.2501077932786591
MPI-CDG	0.00666667	0.2501077932786591
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.00666667	0.2501077932786591
LEPRECHAUNISM	0.00666667	0.2501077932786591
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2	0.00666667	0.2501077932786591
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.00666667	0.2501077932786591
HEMOCHROMATOSIS, NEONATAL	0.00666667	0.2501077932786591
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00666667	0.2501077932786591
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.00666667	0.2501077932786591
PARIETAL FORAMINA	0.005917759	0.22201153569097082
OPTIC PATHWAY GLIOMA	0.005917759	0.22201153569097082
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.005917759	0.22201153569097082
GLIOBLASTOMA	0.005917759	0.22201153569097082
LHERMITTE-DUCLOS DISEASE	0.005917759	0.22201153569097082
ADIPOSIS DOLOROSA	0.005917759	0.22201153569097082
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.005917759	0.22201153569097082
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.005917759	0.22201153569097082
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.005917759	0.22201153569097082
CRANIOPHARYNGIOMA	0.005917759	0.22201153569097082
WYBURN-MASON SYNDROME	0.005917759	0.22201153569097082
NON-FUNCTIONING PITUITARY ADENOMA	0.005917759	0.22201153569097082
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.005917759	0.22201153569097082
L1 SYNDROME	0.005917759	0.22201153569097082
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.005917759	0.22201153569097082
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.005917759	0.22201153569097082
PROLACTINOMA	0.005917759	0.22201153569097082
NEUROFIBROMATOSIS TYPE 1	0.005917759	0.22201153569097082
NARP SYNDROME	0.005917759	0.22201153569097082
PINEOBLASTOMA	0.005917759	0.22201153569097082
CRANIOSYNOSTOSIS 2	0.005917759	0.22201153569097082
15Q OVERGROWTH SYNDROME	0.005917759	0.22201153569097082
TSH-SECRETING PITUITARY ADENOMA	0.005917759	0.22201153569097082
FAMILIAL THROMBOCYTOSIS	0.005917759	0.22201153569097082
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.005917759	0.22201153569097082
NEUROFIBROMATOSIS, TYPE II	0.005917759	0.22201153569097082
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.005917759	0.22201153569097082
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.005917759	0.22201153569097082
PAPILLOMA OF CHOROID PLEXUS	0.005917759	0.22201153569097082
EBOLA HEMORRHAGIC FEVER	0.005917759	0.22201153569097082
HEMANGIOBLASTOMA	0.00537634	0.20169957914757836
CAMURATI-ENGELMANN DISEASE	0.00537634	0.20169957914757836
CENTRAL NEUROCYTOMA	0.00537634	0.20169957914757836
THYMIC TUMOR	0.00537634	0.20169957914757836
PARKES WEBER SYNDROME	0.00537634	0.20169957914757836
SOLAR URTICARIA	0.00537634	0.20169957914757836
TURCOT SYNDROME WITH POLYPOSIS	0.00537634	0.20169957914757836
PINEOCYTOMA	0.00537634	0.20169957914757836
MYXOPAPILLARY EPENDYMOMA	0.00537634	0.20169957914757836
MIDDLE EAR NEUROENDOCRINE TUMOR	0.00537634	0.20169957914757836
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.00537634	0.20169957914757836
INTERNAL CAROTID AGENESIS	0.00537634	0.20169957914757836
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.00537634	0.20169957914757836
PITUICYTOMA	0.00537634	0.20169957914757836
PITUITARY CARCINOMA	0.00537634	0.20169957914757836
FAMILIAL HYPERALDOSTERONISM TYPE III	0.00537634	0.20169957914757836
PANHYPOPHYSITIS	0.00537634	0.20169957914757836
SCLEROSTEOSIS 1; SOST1	0.00537634	0.20169957914757836
ADENOHYPOPHYSITIS	0.00537634	0.20169957914757836
ACROOSTEOLYSIS DOMINANT TYPE	0.00537634	0.20169957914757836
CARNEY TRIAD	0.00537634	0.20169957914757836
FAMILIAL HYPERALDOSTERONISM TYPE II	0.00537634	0.20169957914757836
PAPILLARY TUMOR OF THE PINEAL REGION	0.00537634	0.20169957914757836
PRIMARY FAMILIAL POLYCYTHEMIA	0.00537634	0.20169957914757836
PERINEURAL CYST	0.00537634	0.20169957914757836
BRUNNER SYNDROME; BRNRS	0.00537634	0.20169957914757836
GLUTAMATE MONOSODIUM SENSITIVITY	0.00537634	0.20169957914757836
EPISODIC ATAXIA, TYPE 1; EA1	0.00537634	0.20169957914757836
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.00537634	0.20169957914757836
CUSHING DISEASE	0.00537634	0.20169957914757836
EPISODIC ATAXIA, TYPE 3	0.00537634	0.20169957914757836
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00537634	0.20169957914757836
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00537634	0.20169957914757836
CUTANEOUS MASTOCYTOSIS	0.00537634	0.20169957914757836
PRIMARY PARATHYROID HYPERPLASIA	0.00537634	0.20169957914757836
IDIOPATHIC PANUVEITIS	0.00537634	0.20169957914757836
HYPER-IGD SYNDROME	0.00537634	0.20169957914757836
CROUZON DISEASE	0.00537634	0.20169957914757836
TEMPI SYNDROME	0.00537634	0.20169957914757836
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.00537634	0.20169957914757836
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.00537634	0.20169957914757836
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.00537634	0.20169957914757836
CUTANEOUS MASTOCYTOMA	0.00537634	0.20169957914757836
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.00537634	0.20169957914757836
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00537634	0.20169957914757836
SEVERE HEMOPHILIA A	0.00537634	0.20169957914757836
CHIARI MALFORMATION TYPE I	0.00537634	0.20169957914757836
FUNCTIONING GONADOTROPIC ADENOMA	0.00537634	0.20169957914757836
FAMILIAL HYPERALDOSTERONISM TYPE I	0.00537634	0.20169957914757836
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00537634	0.20169957914757836
MANGANESE POISONING	0.00537634	0.20169957914757836
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.00537634	0.20169957914757836
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.00537634	0.20169957914757836
COLD AGGLUTININ DISEASE	0.00537634	0.20169957914757836
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.00537634	0.20169957914757836
SYSTEMIC MASTOCYTOSIS	0.00537634	0.20169957914757836
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00537634	0.20169957914757836
PARATHYROID CARCINOMA	0.00537634	0.20169957914757836
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.00537634	0.20169957914757836
JUVENILE TEMPORAL ARTERITIS	0.00537634	0.20169957914757836
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00537634	0.20169957914757836
SUSAC SYNDROME	0.00537634	0.20169957914757836
ALPORT SYNDROME	0.00537634	0.20169957914757836
EPISODIC ATAXIA TYPE 1	0.00537634	0.20169957914757836
PRIMARY CILIARY DYSKINESIA	0.00537634	0.20169957914757836
SYDENHAM CHOREA	0.00537634	0.20169957914757836
CONGENITAL TOXOPLASMOSIS	0.0044629890000000005	0.16743416581545653
17Q12 MICRODELETION SYNDROME	0.0044629890000000005	0.16743416581545653
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.0044629890000000005	0.16743416581545653
SIALURIA	0.0044629890000000005	0.16743416581545653
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.0044629890000000005	0.16743416581545653
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.0044629890000000005	0.16743416581545653
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.0044629890000000005	0.16743416581545653
CHOREOACANTHOCYTOSIS	0.0044629890000000005	0.16743416581545653
OROFACIODIGITAL SYNDROME TYPE 1	0.0044629890000000005	0.16743416581545653
SRD5A3-CDG	0.0044629890000000005	0.16743416581545653
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0044629890000000005	0.16743416581545653
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.0044629890000000005	0.16743416581545653
RETINITIS PIGMENTOSA 59; RP59	0.0044629890000000005	0.16743416581545653
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0044629890000000005	0.16743416581545653
ATAXIA-TELANGIECTASIA	0.0044629890000000005	0.16743416581545653
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.0044629890000000005	0.16743416581545653
IMMUNODEFICIENCY 47	0.0044629890000000005	0.16743416581545653
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.0044629890000000005	0.16743416581545653
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.0044629890000000005	0.16743416581545653
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0044629890000000005	0.16743416581545653
COG5-CDG	0.0044629890000000005	0.16743416581545653
PREECLAMPSIA/ECLAMPSIA 1	0.0044629890000000005	0.16743416581545653
ALG11-CDG	0.0044629890000000005	0.16743416581545653
ISOLATED BILIARY ATRESIA	0.0044629890000000005	0.16743416581545653
CLASSIC HOMOCYSTINURIA	0.0044629890000000005	0.16743416581545653
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.0044629890000000005	0.16743416581545653
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0044629890000000005	0.16743416581545653
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.0044629890000000005	0.16743416581545653
DDOST-CDG	0.0044629890000000005	0.16743416581545653
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.0044629890000000005	0.16743416581545653
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.0044629890000000005	0.16743416581545653
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.0044629890000000005	0.16743416581545653
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.0044629890000000005	0.16743416581545653
COACH SYNDROME	0.0044629890000000005	0.16743416581545653
LATHOSTEROLOSIS	0.0044629890000000005	0.16743416581545653
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.004329299	0.16241863169071
ASPARTYLGLUCOSAMINURIA; AGU	0.004329299	0.16241863169071
GAPO SYNDROME; GAPOS	0.004329299	0.16241863169071
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.004329299	0.16241863169071
CHROMOSOME 10Q26 DELETION SYNDROME	0.004329299	0.16241863169071
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.004329299	0.16241863169071
SALLA DISEASE	0.004329299	0.16241863169071
ICHTHYOSIS AND MALE HYPOGONADISM	0.004329299	0.16241863169071
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.004329299	0.16241863169071
HYPERLEUCINE-ISOLEUCINEMIA	0.004329299	0.16241863169071
EMANUEL SYNDROME	0.004329299	0.16241863169071
XYLOSIDASE DEFICIENCY	0.004329299	0.16241863169071
EPILEPSY-TELANGIECTASIA	0.004329299	0.16241863169071
NEURONAL CEROID LIPOFUSCINOSIS	0.004329299	0.16241863169071
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.004329299	0.16241863169071
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.004329299	0.16241863169071
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004329299	0.16241863169071
BARAITSER-WINTER SYNDROME 1; BRWS1	0.004329299	0.16241863169071
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.004329299	0.16241863169071
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.004329299	0.16241863169071
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.004329299	0.16241863169071
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.004329299	0.16241863169071
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.004329299	0.16241863169071
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.004329299	0.16241863169071
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.004329299	0.16241863169071
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.004329299	0.16241863169071
FABRY DISEASE	0.004272759	0.16029746855649527
PORPHYRIA	0.004272759	0.16029746855649527
FAMILIAL MEDITERRANEAN FEVER	0.004272759	0.16029746855649527
HYPOPHOSPHATASIA, INFANTILE	0.004272759	0.16029746855649527
CHÉDIAK-HIGASHI SYNDROME	0.004272759	0.16029746855649527
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.004272759	0.16029746855649527
NEPHROGENIC DIABETES INSIPIDUS	0.004272759	0.16029746855649527
WHIPPLE DISEASE	0.004272759	0.16029746855649527
MIXED CONNECTIVE TISSUE DISEASE	0.004272759	0.16029746855649527
XERODERMA PIGMENTOSUM	0.004272759	0.16029746855649527
GRISCELLI SYNDROME TYPE 2	0.004272759	0.16029746855649527
MICROSPORIDIOSIS	0.004272759	0.16029746855649527
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.004272759	0.16029746855649527
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.004272759	0.16029746855649527
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.004272759	0.16029746855649527
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.004272759	0.16029746855649527
GRISCELLI SYNDROME	0.004272759	0.16029746855649527
LYMPHANGIOLEIOMYOMATOSIS	0.004272759	0.16029746855649527
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.004272759	0.16029746855649527
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.004272759	0.16029746855649527
CHRONIC GRAFT VERSUS HOST DISEASE	0.00392157	0.14712220927206404
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.00392157	0.14712220927206404
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00392157	0.14712220927206404
JEJUNAL NEUROENDOCRINE TUMOR	0.00392157	0.14712220927206404
HEMOCHROMATOSIS, TYPE 1	0.00392157	0.14712220927206404
ILEAL NEUROENDOCRINE TUMOR	0.00392157	0.14712220927206404
GLYCINE N-METHYLTRANSFERASE DEFICIENCY	0.00392157	0.14712220927206404
DUODENAL NEUROENDOCRINE TUMOR	0.00392157	0.14712220927206404
CHYLOMICRON RETENTION DISEASE	0.00392157	0.14712220927206404
NEUROENDOCRINE TUMOR OF THE COLON	0.00392157	0.14712220927206404
TURNER SYNDROME	0.00392157	0.14712220927206404
MONOSOMY X	0.00392157	0.14712220927206404
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.00392157	0.14712220927206404
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.00392157	0.14712220927206404
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.00392157	0.14712220927206404
MOSAIC MONOSOMY X	0.00392157	0.14712220927206404
DPM3-CDG	0.00392157	0.14712220927206404
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00392157	0.14712220927206404
NEPHROPATHY, PROGRESSIVE TUBULOINTERSTITIAL, WITH CHOLESTATIC LIVERDISEASE	0.00392157	0.14712220927206404
CARCINOID SYNDROME	0.00392157	0.14712220927206404
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00392157	0.14712220927206404
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.00392157	0.14712220927206404
NEUROENDOCRINE TUMOR OF STOMACH	0.00392157	0.14712220927206404
HEMOCHROMATOSIS, TYPE 3; HFE3	0.00392157	0.14712220927206404
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.00392157	0.14712220927206404
LYSINURIC PROTEIN INTOLERANCE	0.00392157	0.14712220927206404
BECKER MUSCULAR DYSTROPHY	0.00392157	0.14712220927206404
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.00392157	0.14712220927206404
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.00392157	0.14712220927206404
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.00392157	0.14712220927206404
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.00392157	0.14712220927206404
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.00392157	0.14712220927206404
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.00392157	0.14712220927206404
DK1-CDG	0.00392157	0.14712220927206404
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00392157	0.14712220927206404
HARDIKAR SYNDROME	0.00392157	0.14712220927206404
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.00392157	0.14712220927206404
NEONATAL LUPUS ERYTHEMATOSUS	0.00392157	0.14712220927206404
GRAFT VERSUS HOST DISEASE	0.00392157	0.14712220927206404
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.00392157	0.14712220927206404
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00392157	0.14712220927206404
HEMOCHROMATOSIS, TYPE 2B	0.00392157	0.14712220927206404
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00392157	0.14712220927206404
TOXIC EPIDERMAL NECROLYSIS	0.00392157	0.14712220927206404
REYNOLDS SYNDROME	0.00392157	0.14712220927206404
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	0.00392157	0.14712220927206404
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00392157	0.14712220927206404
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 1	0.00392157	0.14712220927206404
RETINITIS PIGMENTOSA 71; RP71	0.00392157	0.14712220927206404
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00392157	0.14712220927206404
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.00392157	0.14712220927206404
%210500 BILIARY ATRESIA, EXTRAHEPATIC; EHBA	0.00392157	0.14712220927206404
ALSTROM SYNDROME; ALMS	0.00392157	0.14712220927206404
INTERSTITIAL NEPHRITIS, KARYOMEGALIC	0.00392157	0.14712220927206404
MCCUNE-ALBRIGHT SYNDROME	0.00392157	0.14712220927206404
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.00392157	0.14712220927206404
HEMOCHROMATOSIS TYPE 2	0.00392157	0.14712220927206404
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00392157	0.14712220927206404
PEDIATRIC-ONSET GRAVES DISEASE	0.00392157	0.14712220927206404
SCLEROSING CHOLANGITIS, NEONATAL	0.00392157	0.14712220927206404
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.00392157	0.14712220927206404
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00392157	0.14712220927206404
X-LINKED SIDEROBLASTIC ANEMIA	0.00392157	0.14712220927206404
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.00392157	0.14712220927206404
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.00392157	0.14712220927206404
AUTOIMMUNE HEPATITIS	0.00392157	0.14712220927206404
BARDET-BIEDL SYNDROME 21; BBS21	0.00392157	0.14712220927206404
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.00392157	0.14712220927206404
RENAL CYSTS AND DIABETES SYNDROME; RCAD	0.00392157	0.14712220927206404
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 3	0.00392157	0.14712220927206404
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.00392157	0.14712220927206404
PULMONARY FIBROSIS-HEPATIC HYPERPLASIA-BONE MARROW HYPOPLASIA SYNDROME	0.00392157	0.14712220927206404
NEUTRAL LIPID STORAGE MYOPATHY	0.00392157	0.14712220927206404
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00392157	0.14712220927206404
MYH9-RELATED DISEASE	0.00392157	0.14712220927206404
DISORDER OF BILE ACID SYNTHESIS	0.00392157	0.14712220927206404
MEVALONIC ACIDURIA; MEVA	0.00392157	0.14712220927206404
COMMON VARIABLE IMMUNODEFICIENCY	0.00392157	0.14712220927206404
FAMILIAL PANCREATIC CARCINOMA	0.00392157	0.14712220927206404
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00392157	0.14712220927206404
XFE PROGEROID SYNDROME; XFEPS	0.00392157	0.14712220927206404
WILSON DISEASE	0.00392157	0.14712220927206404
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 2	0.00392157	0.14712220927206404
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00392157	0.14712220927206404
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.1421066751473175
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00378788	0.1421066751473175
46,XX GONADAL DYSGENESIS	0.00378788	0.1421066751473175
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.1421066751473175
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.1421066751473175
ALAND ISLAND EYE DISEASE	0.00378788	0.1421066751473175
CALVARIAL HYPEROSTOSIS	0.00378788	0.1421066751473175
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.1421066751473175
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.1421066751473175
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.1421066751473175
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.1421066751473175
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00378788	0.1421066751473175
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.1421066751473175
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.1421066751473175
REFSUM DISEASE	0.00378788	0.1421066751473175
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.1421066751473175
REVESZ SYNDROME	0.00378788	0.1421066751473175
BLOOD GROUP, DUFFY SYSTEM; FY	0.00378788	0.1421066751473175
BEETURIA	0.00378788	0.1421066751473175
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.1421066751473175
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.1421066751473175
PYGMY	0.00378788	0.1421066751473175
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	0.1421066751473175
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00378788	0.1421066751473175
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.1421066751473175
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.1421066751473175
PROGESTERONE RESISTANCE	0.00378788	0.1421066751473175
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00378788	0.1421066751473175
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	0.1421066751473175
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	0.1421066751473175
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.1421066751473175
PITUITARY DWARFISM IV	0.00378788	0.1421066751473175
LARON SYNDROME	0.00378788	0.1421066751473175
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.1421066751473175
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.1421066751473175
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.1421066751473175
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.1421066751473175
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.1421066751473175
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.1421066751473175
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.1421066751473175
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.1421066751473175
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00378788	0.1421066751473175
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	0.1421066751473175
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.1421066751473175
CARBOXYLESTERASE 1	0.00378788	0.1421066751473175
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.1421066751473175
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.1421066751473175
MACULAR CORNEAL DYSTROPHY	0.00378788	0.1421066751473175
MYELOPEROXIDASE DEFICIENCY	0.00378788	0.1421066751473175
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.1421066751473175
COUMARIN RESISTANCE	0.00378788	0.1421066751473175
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.1421066751473175
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.1421066751473175
BARTTER SYNDROME	0.00378788	0.1421066751473175
XANTHINURIA, TYPE I	0.00378788	0.1421066751473175
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.00378788	0.1421066751473175
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.1421066751473175
T-SUBSTANCE ANOMALY	0.00378788	0.1421066751473175
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00378788	0.1421066751473175
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00378788	0.1421066751473175
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	0.1421066751473175
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00378788	0.1421066751473175
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.1421066751473175
PENDRED SYNDROME	0.00378788	0.1421066751473175
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.1421066751473175
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00378788	0.1421066751473175
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.1421066751473175
CUTIS LAXA	0.00378788	0.1421066751473175
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	0.1421066751473175
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00378788	0.1421066751473175
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.1421066751473175
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.1421066751473175
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.1421066751473175
NEPHROSIALIDOSIS	0.00378788	0.1421066751473175
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.1421066751473175
TRISOMY 18-LIKE SYNDROME	0.00378788	0.1421066751473175
LARSEN-LIKE SYNDROME	0.00378788	0.1421066751473175
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.1421066751473175
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.1421066751473175
%608572 BURN-MCKEOWN SYNDROME	0.00378788	0.1421066751473175
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00378788	0.1421066751473175
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.1421066751473175
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.1421066751473175
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.1421066751473175
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.1421066751473175
SPINAL ARACHNOIDITIS	0.00378788	0.1421066751473175
OSTEOGENIC SARCOMA	0.00378788	0.1421066751473175
AREDYLD	0.00378788	0.1421066751473175
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.1421066751473175
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.1421066751473175
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.1421066751473175
OSTEOMESOPYKNOSIS	0.00378788	0.1421066751473175
GLUTATHIONURIA	0.00378788	0.1421066751473175
ETHANOLAMINOSIS	0.00378788	0.1421066751473175
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.1421066751473175
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00378788	0.1421066751473175
HOOFT DISEASE	0.00378788	0.1421066751473175
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.00378788	0.1421066751473175
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.1421066751473175
DERMATITIS, ATOPIC	0.00378788	0.1421066751473175
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.1421066751473175
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.1421066751473175
APOLIPOPROTEIN(A)	0.00378788	0.1421066751473175
CEPHALIN LIPIDOSIS	0.00378788	0.1421066751473175
HYPOASCORBEMIA	0.00378788	0.1421066751473175
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.1421066751473175
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00378788	0.1421066751473175
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.1421066751473175
OVARIAN CANCER	0.00378788	0.1421066751473175
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00378788	0.1421066751473175
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.1421066751473175
PARAOXONASE 1	0.00378788	0.1421066751473175
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.1421066751473175
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.1421066751473175
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.1421066751473175
CONGENITAL ADRENAL HYPERPLASIA	0.00378788	0.1421066751473175
CITRULLINE TRANSPORT DEFECT	0.00378788	0.1421066751473175
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00378788	0.1421066751473175
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.1421066751473175
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00378788	0.1421066751473175
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.1421066751473175
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.1421066751473175
CARDIAC LIPIDOSIS, FAMILIAL	0.00378788	0.1421066751473175
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.1421066751473175
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	0.1421066751473175
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.1421066751473175
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.1421066751473175
PACMAN DYSPLASIA	0.00378788	0.1421066751473175
PERRY SYNDROME	0.00378788	0.1421066751473175
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.1421066751473175
DERMATOLEUKODYSTROPHY	0.00378788	0.1421066751473175
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	0.1421066751473175
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.1421066751473175
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.1421066751473175
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.1421066751473175
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.1421066751473175
MYOPATHY, SPHEROID BODY	0.00378788	0.1421066751473175
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00378788	0.1421066751473175
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00378788	0.1421066751473175
EHLERS-DANLOS SYNDROME, TYPE VI	0.00378788	0.1421066751473175
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.1421066751473175
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.1421066751473175
ACETYLATION, SLOW	0.00378788	0.1421066751473175
KERATOSIS, FAMILIAL ACTINIC	0.00378788	0.1421066751473175
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.1421066751473175
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00378788	0.1421066751473175
HEINZ BODY ANEMIAS	0.00378788	0.1421066751473175
GLUTATHIONE REDUCTASE	0.00378788	0.1421066751473175
GLOMUVENOUS MALFORMATIONS	0.00378788	0.1421066751473175
ONCOCYTOMA	0.00378788	0.1421066751473175
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.1421066751473175
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00378788	0.1421066751473175
FLOOD FACTOR DEFICIENCY	0.00378788	0.1421066751473175
GONADOBLASTOMA	0.00378788	0.1421066751473175
DELETED IN AZOOSPERMIA	0.00378788	0.1421066751473175
XM SYSTEM	0.00378788	0.1421066751473175
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.1421066751473175
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00378788	0.1421066751473175
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.1421066751473175
PREMATURE OVARIAN FAILURE 1	0.00378788	0.1421066751473175
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00378788	0.1421066751473175
ZINC, ELEVATED PLASMA	0.00378788	0.1421066751473175
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.1421066751473175
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.1421066751473175
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.1421066751473175
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.1421066751473175
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.1421066751473175
ICHTHYOSIS, X-LINKED	0.00378788	0.1421066751473175
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.1421066751473175
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.1421066751473175
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	0.1421066751473175
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.1421066751473175
FINGERPRINT BODY MYOPATHY	0.00378788	0.1421066751473175
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.1421066751473175
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.1421066751473175
LYMPHOKINE DEFICIENCY	0.00378788	0.1421066751473175
MACROCYTOSIS, FAMILIAL	0.00378788	0.1421066751473175
CEREBELLOPARENCHYMAL DISORDER V	0.00378788	0.1421066751473175
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.1421066751473175
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.1421066751473175
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.1421066751473175
ALKAPTONURIA	0.00378788	0.1421066751473175
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00378788	0.1421066751473175
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.1421066751473175
SCHIZOPHRENIA 4	0.00378788	0.1421066751473175
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.1421066751473175
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.1421066751473175
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00378788	0.1421066751473175
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	0.1421066751473175
HYPERPROGLUCAGONEMIA	0.00378788	0.1421066751473175
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.1421066751473175
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.1421066751473175
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.1421066751473175
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.1421066751473175
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00378788	0.1421066751473175
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.1421066751473175
LIPASE DEFICIENCY, COMBINED	0.00378788	0.1421066751473175
KUFOR-RAKEB SYNDROME	0.00373134	0.13998551201310278
POLYEMBRYOMA	0.00373134	0.13998551201310278
TETANUS	0.00373134	0.13998551201310278
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.00373134	0.13998551201310278
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00373134	0.13998551201310278
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.00373134	0.13998551201310278
OMENN SYNDROME	0.00373134	0.13998551201310278
ERDHEIM-CHESTER DISEASE	0.00373134	0.13998551201310278
RETICULAR DYSGENESIS	0.00373134	0.13998551201310278
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.00373134	0.13998551201310278
NODULAR NON-SUPPURATIVE PANNICULITIS	0.00373134	0.13998551201310278
MELIOIDOSIS	0.00373134	0.13998551201310278
ROTOR SYNDROME	0.00373134	0.13998551201310278
JUVENILE DERMATOMYOSITIS	0.00373134	0.13998551201310278
WOUND BOTULISM	0.00373134	0.13998551201310278
ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE	0.00373134	0.13998551201310278
CONGENITAL FIBRINOGEN DEFICIENCY	0.00373134	0.13998551201310278
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO CD3DELTA/CD3EPSILON/CD3ZETA	0.00373134	0.13998551201310278
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00373134	0.13998551201310278
SEVERE COMBINED IMMUNODEFICIENCY	0.00373134	0.13998551201310278
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.00373134	0.13998551201310278
SCHNITZLER SYNDROME	0.00373134	0.13998551201310278
TUBERCULOSIS	0.00373134	0.13998551201310278
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.00373134	0.13998551201310278
BACTERIAL SUSCEPTIBILITY DUE TO TLR SIGNALING PATHWAY DEFICIENCY	0.00373134	0.13998551201310278
JUVENILE IDIOPATHIC ARTHRITIS	0.00373134	0.13998551201310278
CHRONIC GRANULOMATOUS DISEASE	0.00373134	0.13998551201310278
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.00373134	0.13998551201310278
SARCOIDOSIS	0.00373134	0.13998551201310278
REYNOLDS SYNDROME	0.00373134	0.13998551201310278
MALT LYMPHOMA	0.00373134	0.13998551201310278
MICROSCOPIC POLYANGIITIS	0.00373134	0.13998551201310278
ACUTE MONOBLASTIC LEUKEMIA	0.00373134	0.13998551201310278
IDIOPATHIC ACUTE EOSINOPHILIC PNEUMONIA	0.00373134	0.13998551201310278
DRUG-INDUCED LUPUS ERYTHEMATOSUS	0.00373134	0.13998551201310278
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00373134	0.13998551201310278
ACUTE PROMYELOCYTIC LEUKEMIA	0.00373134	0.13998551201310278
CHRONIC MYELOID LEUKEMIA	0.00373134	0.13998551201310278
MANTLE CELL LYMPHOMA	0.00373134	0.13998551201310278
CHOLANGIOCARCINOMA	0.00373134	0.13998551201310278
DUBIN-JOHNSON SYNDROME	0.00373134	0.13998551201310278
PYOGENIC ARTHRITIS-PYODERMA GANGRENOSUM-ACNE SYNDROME	0.00373134	0.13998551201310278
OSTEOSARCOMA	0.00373134	0.13998551201310278
NEPHROBLASTOMA	0.00373134	0.13998551201310278
CRYOGLOBULINEMIC VASCULITIS	0.00373134	0.13998551201310278
PULMONARY BLASTOMA	0.00373134	0.13998551201310278
HEREDITARY SPHEROCYTOSIS	0.00373134	0.13998551201310278
FOLLICULAR LYMPHOMA	0.00373134	0.13998551201310278
ANTISYNTHETASE SYNDROME	0.00373134	0.13998551201310278
MALAKOPLAKIA	0.00373134	0.13998551201310278
LATE-ONSET FAMILIAL HYPOALDOSTERONISM	0.00373134	0.13998551201310278
MUCKLE-WELLS SYNDROME	0.00373134	0.13998551201310278
CONGENITAL PRIMARY MEGAURETER	0.00373134	0.13998551201310278
MACROPHAGIC MYOFASCIITIS	0.00373134	0.13998551201310278
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.00373134	0.13998551201310278
MELKERSSON-ROSENTHAL SYNDROME	0.00373134	0.13998551201310278
FAMILIAL ATRIAL MYXOMA	0.00373134	0.13998551201310278
POLYMYOSITIS	0.00373134	0.13998551201310278
ISOLATED AGAMMAGLOBULINEMIA	0.00373134	0.13998551201310278
SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS	0.00373134	0.13998551201310278
ADULT IDIOPATHIC NEUTROPENIA	0.00373134	0.13998551201310278
REACTIVE ARTHRITIS	0.00373134	0.13998551201310278
CONGENITAL ENTEROVIRUS INFECTION	0.00373134	0.13998551201310278
WISKOTT-ALDRICH SYNDROME	0.00373134	0.13998551201310278
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.00373134	0.13998551201310278
WELLS SYNDROME	0.00373134	0.13998551201310278
HEREDITARY ELLIPTOCYTOSIS	0.00373134	0.13998551201310278
MIXED-TYPE AUTOIMMUNE HEMOLYTIC ANEMIA	0.00373134	0.13998551201310278
POLYARTERITIS NODOSA	0.00373134	0.13998551201310278
CYSTINOSIS	0.00373134	0.13998551201310278
PYOMYOSITIS	0.00373134	0.13998551201310278
IDIOPATHIC BRONCHIECTASIS	0.00373134	0.13998551201310278
KAPOSIFORM LYMPHANGIOMATOSIS	0.00373134	0.13998551201310278
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.00373134	0.13998551201310278
WOLMAN DISEASE	0.00373134	0.13998551201310278
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.00373134	0.13998551201310278
DERMATOMYOSITIS	0.00373134	0.13998551201310278
X-LINKED AGAMMAGLOBULINEMIA	0.00373134	0.13998551201310278
CUTANEOUS SMALL VESSEL VASCULITIS	0.00373134	0.13998551201310278
PYODERMA GANGRENOSUM	0.00373134	0.13998551201310278
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.00373134	0.13998551201310278
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.00373134	0.13998551201310278
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.00373134	0.13998551201310278
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.00373134	0.13998551201310278
FOCAL MYOSITIS	0.00373134	0.13998551201310278
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.00373134	0.13998551201310278
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.00373134	0.13998551201310278
KLATSKIN TUMOR	0.00373134	0.13998551201310278
GLYCOGEN STORAGE DISEASE II	0.00373134	0.13998551201310278
MYELOFIBROSISMYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED	0.00373134	0.13998551201310278
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00373134	0.13998551201310278
CRYPTOGENIC ORGANIZING PNEUMONIA	0.00373134	0.13998551201310278
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.00373134	0.13998551201310278
CAFFEY DISEASE	0.00373134	0.13998551201310278
STIFF-PERSON SYNDROME; SPS	0.00373134	0.13998551201310278
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00373134	0.13998551201310278
RAGWEED SENSITIVITY	0.00373134	0.13998551201310278
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.00373134	0.13998551201310278
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.00373134	0.13998551201310278
PANCREATITIS, HEREDITARY	0.00373134	0.13998551201310278
MULTICENTRIC RETICULOHISTIOCYTOSIS	0.00373134	0.13998551201310278
NEUROPATHY, PAINFUL	0.00373134	0.13998551201310278
CYCLIC NEUTROPENIA	0.00373134	0.13998551201310278
CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.00373134	0.13998551201310278
PSORIASIS 14, PUSTULAR	0.00373134	0.13998551201310278
PSEUDODIASTROPHIC DYSPLASIA	0.00373134	0.13998551201310278
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.00373134	0.13998551201310278
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.00373134	0.13998551201310278
CIRRHOSIS, FAMILIAL	0.00373134	0.13998551201310278
AREGENERATIVE ANEMIA	0.00373134	0.13998551201310278
HALOTHANE HEPATITIS	0.00373134	0.13998551201310278
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5	0.00373134	0.13998551201310278
NEUROPATHY, HEREDITARY THERMOSENSITIVE	0.00373134	0.13998551201310278
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.00373134	0.13998551201310278
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00373134	0.13998551201310278
FEVER, FAMILIAL LIFELONG PERSISTENT	0.00373134	0.13998551201310278
IMMUNODEFICIENCY 32B; IMD32B	0.00373134	0.13998551201310278
HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES	0.00373134	0.13998551201310278
MU-HEAVY CHAIN DISEASE	0.00373134	0.13998551201310278
ALPHA-HEAVY CHAIN DISEASE	0.00373134	0.13998551201310278
GAMMA-HEAVY CHAIN DISEASE	0.00373134	0.13998551201310278
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.00373134	0.13998551201310278
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.00373134	0.13998551201310278
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4	0.00373134	0.13998551201310278
CINCA SYNDROME; CINCA	0.00373134	0.13998551201310278
RHABDOMYOLYSIS, ACUTE RECURRENT	0.00373134	0.13998551201310278
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.00373134	0.13998551201310278
DYSTONIA 12; DYT12	0.00373134	0.13998551201310278
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00373134	0.13998551201310278
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00373134	0.13998551201310278
PROGRESSIVE NODULAR HISTIOCYTOSIS	0.00373134	0.13998551201310278
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.00373134	0.13998551201310278
CAFFEY DISEASE	0.00373134	0.13998551201310278
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000541419	0.02031195654339248
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000541419	0.02031195654339248
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.000541419	0.02031195654339248
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000541419	0.02031195654339248
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.000541419	0.02031195654339248
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000541419	0.02031195654339248
WIEACKER-WOLFF SYNDROME	0.000541419	0.02031195654339248
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000541419	0.02031195654339248
17Q24.2 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.02031195654339248
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.000541419	0.02031195654339248
OCULOECTODERMAL SYNDROME; OES	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000541419	0.02031195654339248
MILLER-DIEKER SYNDROME	0.000541419	0.02031195654339248
LIPOID PROTEINOSIS	0.000541419	0.02031195654339248
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.000541419	0.02031195654339248
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.000541419	0.02031195654339248
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.02031195654339248
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.000541419	0.02031195654339248
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.02031195654339248
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.02031195654339248
BAND HETEROTOPIA; BH	0.000541419	0.02031195654339248
OROFACIODIGITAL SYNDROME I; OFD1	0.000541419	0.02031195654339248
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.02031195654339248
WAISMAN SYNDROME; WSMN	0.000541419	0.02031195654339248
PELIZAEUS-MERZBACHER DISEASE	0.000541419	0.02031195654339248
RETT SYNDROME; RTT	0.000541419	0.02031195654339248
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.02031195654339248
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.02031195654339248
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.000541419	0.02031195654339248
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000541419	0.02031195654339248
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000541419	0.02031195654339248
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000541419	0.02031195654339248
8Q24.3 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.000541419	0.02031195654339248
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000541419	0.02031195654339248
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.02031195654339248
POTOCKI-SHAFFER SYNDROME	0.000541419	0.02031195654339248
MAPLE SYRUP URINE DISEASE	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.02031195654339248
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.02031195654339248
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.02031195654339248
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.02031195654339248
GURRIERI SYNDROME	0.000541419	0.02031195654339248
ANGELMAN SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 9	0.000541419	0.02031195654339248
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.02031195654339248
WHIM SYNDROME	0.000541419	0.02031195654339248
ATKIN-FLAITZ SYNDROME	0.000541419	0.02031195654339248
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.000541419	0.02031195654339248
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.02031195654339248
CHROMOSOME 2Q37 DELETION SYNDROME	0.000541419	0.02031195654339248
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.02031195654339248
CODAS SYNDROME	0.000541419	0.02031195654339248
XQ25 MICRODUPLICATION SYNDROME	0.000541419	0.02031195654339248
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.02031195654339248
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000541419	0.02031195654339248
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.02031195654339248
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.02031195654339248
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.02031195654339248
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.02031195654339248
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000541419	0.02031195654339248
NIEMANN-PICK DISEASE TYPE C	0.000541419	0.02031195654339248
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.000541419	0.02031195654339248
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.000541419	0.02031195654339248
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.000541419	0.02031195654339248
ALSTRÖM SYNDROME	0.000541419	0.02031195654339248
SHUKLA-VERNON SYNDROME; SHUVER	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.02031195654339248
NETHERTON SYNDROME	0.000541419	0.02031195654339248
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.000541419	0.02031195654339248
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000541419	0.02031195654339248
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.000541419	0.02031195654339248
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.02031195654339248
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000541419	0.02031195654339248
NEVUS COMEDONICUS SYNDROME	0.000541419	0.02031195654339248
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 103	0.000541419	0.02031195654339248
LEBER CONGENITAL AMAUROSIS	0.000541419	0.02031195654339248
XQ25 DUPLICATION SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.000541419	0.02031195654339248
MEND SYNDROME; MEND	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.02031195654339248
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.02031195654339248
ONDINE SYNDROME	0.000541419	0.02031195654339248
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.02031195654339248
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.000541419	0.02031195654339248
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.000541419	0.02031195654339248
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.02031195654339248
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000541419	0.02031195654339248
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000541419	0.02031195654339248
MYASTHENIA GRAVIS	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.02031195654339248
RENPENNING SYNDROME 1; RENS1	0.000541419	0.02031195654339248
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.02031195654339248
MENKES DISEASE	0.000541419	0.02031195654339248
INCONTINENTIA PIGMENTI; IP	0.000541419	0.02031195654339248
22Q11.2 DELETION SYNDROME	0.000541419	0.02031195654339248
MICROPHTHALMIA, LENZ TYPE	0.000541419	0.02031195654339248
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.000541419	0.02031195654339248
ALEXANDER DISEASE	0.000541419	0.02031195654339248
CLARK-BARAITSER SYNDROME	0.000541419	0.02031195654339248
MUCOPOLYSACCHARIDOSIS TYPE 2	0.000541419	0.02031195654339248
MUCOPOLYSACCHARIDOSIS TYPE 3	0.000541419	0.02031195654339248
MULTIPLE SULFATASE DEFICIENCY	0.000541419	0.02031195654339248
MUSCLE-EYE-BRAIN DISEASE	0.000541419	0.02031195654339248
CONGENITAL MYASTHENIC SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 88	0.000541419	0.02031195654339248
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.02031195654339248
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.02031195654339248
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.02031195654339248
HHHH SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.02031195654339248
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.000541419	0.02031195654339248
PETTIGREW SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.02031195654339248
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.02031195654339248
COFFIN-LOWRY SYNDROME; CLS	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 90	0.000541419	0.02031195654339248
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000541419	0.02031195654339248
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.02031195654339248
CENTRONUCLEAR MYOPATHY	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.000541419	0.02031195654339248
LEIGH SYNDROME	0.000541419	0.02031195654339248
POTOCKI-LUPSKI SYNDROME	0.000541419	0.02031195654339248
CHROMOSOME 16P13.3 DELETION SYNDROME	0.000541419	0.02031195654339248
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.02031195654339248
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000541419	0.02031195654339248
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.02031195654339248
CORNELIA DE LANGE SYNDROME 3	0.000541419	0.02031195654339248
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000541419	0.02031195654339248
HOLOPROSENCEPHALY 7	0.000541419	0.02031195654339248
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.02031195654339248
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.02031195654339248
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.02031195654339248
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000541419	0.02031195654339248
HYPOPHOSPHATASIA	0.000541419	0.02031195654339248
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.02031195654339248
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.000541419	0.02031195654339248
KEPPEN-LUBINSKY SYNDROME	0.000541419	0.02031195654339248
PGM3-CDG	0.000541419	0.02031195654339248
11Q22.2Q22.3 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.000541419	0.02031195654339248
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000541419	0.02031195654339248
SCHINDLER DISEASE, TYPE I	0.000541419	0.02031195654339248
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.000541419	0.02031195654339248
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.000541419	0.02031195654339248
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000541419	0.02031195654339248
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000541419	0.02031195654339248
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.02031195654339248
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.02031195654339248
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000541419	0.02031195654339248
KLEEFSTRA SYNDROME	0.000541419	0.02031195654339248
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.000541419	0.02031195654339248
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.02031195654339248
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.02031195654339248
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.02031195654339248
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.000541419	0.02031195654339248
KOOLEN-DE VRIES SYNDROME; KDVS	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.02031195654339248
PHACE SYNDROME	0.000541419	0.02031195654339248
GLASS SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.000541419	0.02031195654339248
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.000541419	0.02031195654339248
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.02031195654339248
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.000541419	0.02031195654339248
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.02031195654339248
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.000541419	0.02031195654339248
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000541419	0.02031195654339248
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000541419	0.02031195654339248
ADNP SYNDROME	0.000541419	0.02031195654339248
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.02031195654339248
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000541419	0.02031195654339248
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000541419	0.02031195654339248
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.02031195654339248
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000541419	0.02031195654339248
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.02031195654339248
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.000541419	0.02031195654339248
LISSENCEPHALY 3; LIS3	0.000541419	0.02031195654339248
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000541419	0.02031195654339248
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000541419	0.02031195654339248
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000541419	0.02031195654339248
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.02031195654339248
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.02031195654339248
TEMPLE-BARAITSER SYNDROME	0.000541419	0.02031195654339248
611961 STEVENSON-CAREY SYNDROME	0.000541419	0.02031195654339248
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
HYPERPROLINEMIA TYPE 1	0.000541419	0.02031195654339248
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.000541419	0.02031195654339248
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.000541419	0.02031195654339248
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000541419	0.02031195654339248
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.02031195654339248
DYSTONIA-APHONIA SYNDROME	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.000541419	0.02031195654339248
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.000541419	0.02031195654339248
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.02031195654339248
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.000541419	0.02031195654339248
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000541419	0.02031195654339248
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.000541419	0.02031195654339248
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.02031195654339248
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000541419	0.02031195654339248
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.02031195654339248
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.02031195654339248
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.000541419	0.02031195654339248
BOHRING-OPITZ SYNDROME	0.000541419	0.02031195654339248
MONOSOMY 22Q13.3	0.000541419	0.02031195654339248
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.02031195654339248
WIEDEMANN-STEINER SYNDROME; WDSTS	0.000541419	0.02031195654339248
PHELAN-MCDERMID SYNDROME	0.000541419	0.02031195654339248
KUFOR-RAKEB SYNDROME	0.000541419	0.02031195654339248
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.000541419	0.02031195654339248
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000541419	0.02031195654339248
9Q33.3Q34.11 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.02031195654339248
MUENKE SYNDROME	0.000541419	0.02031195654339248
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.02031195654339248
PALLISTER-KILLIAN SYNDROME	0.000541419	0.02031195654339248
CHROMOSOME 18Q DELETION SYNDROME	0.000541419	0.02031195654339248
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.02031195654339248
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.000541419	0.02031195654339248
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.02031195654339248
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.000541419	0.02031195654339248
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.000541419	0.02031195654339248
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 72	0.000541419	0.02031195654339248
16P13.2 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
PIERPONT SYNDROME	0.000541419	0.02031195654339248
GRACILE BONE DYSPLASIA; GCLEB	0.000541419	0.02031195654339248
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000541419	0.02031195654339248
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.02031195654339248
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.000541419	0.02031195654339248
KALLMANN SYNDROME	0.000541419	0.02031195654339248
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000541419	0.02031195654339248
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.000541419	0.02031195654339248
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02031195654339248
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000541419	0.02031195654339248
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.000541419	0.02031195654339248
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000541419	0.02031195654339248
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.02031195654339248
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.02031195654339248
INCONTINENTIA PIGMENTI	0.000541419	0.02031195654339248
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.02031195654339248
LATHOSTEROLOSIS	0.000541419	0.02031195654339248
ADENYLOSUCCINATE LYASE DEFICIENCY	0.000541419	0.02031195654339248
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.02031195654339248
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000541419	0.02031195654339248
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000541419	0.02031195654339248
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.000541419	0.02031195654339248
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.000541419	0.02031195654339248
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.02031195654339248
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000541419	0.02031195654339248
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02031195654339248
JOUBERT SYNDROME	0.000541419	0.02031195654339248
LISSENCEPHALY 1; LIS1	0.000541419	0.02031195654339248
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.02031195654339248
NIEMANN-PICK DISEASE, TYPE C2	0.000541419	0.02031195654339248
ALZHEIMER DISEASE 3; AD	0.000541419	0.02031195654339248
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.02031195654339248
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000541419	0.02031195654339248
GAUCHER DISEASE, PERINATAL LETHAL	0.000541419	0.02031195654339248
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.000541419	0.02031195654339248
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.02031195654339248
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000541419	0.02031195654339248
KAGAMI-OGATA SYNDROME	0.000541419	0.02031195654339248
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000541419	0.02031195654339248
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000541419	0.02031195654339248
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.02031195654339248
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.02031195654339248
THANATOPHORIC DYSPLASIA TYPE 2	0.000541419	0.02031195654339248
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.02031195654339248
PFEIFFER SYNDROME TYPE 3	0.000541419	0.02031195654339248
PFEIFFER SYNDROME TYPE 2	0.000541419	0.02031195654339248
AUTISM	0.000541419	0.02031195654339248
ASPARTYLGLUCOSAMINURIA	0.000541419	0.02031195654339248
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000541419	0.02031195654339248
SECKEL SYNDROME 1; SCKL1	0.000541419	0.02031195654339248
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.000541419	0.02031195654339248
BANGSTAD SYNDROME	0.000541419	0.02031195654339248
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.02031195654339248
C SYNDROME	0.000541419	0.02031195654339248
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.000541419	0.02031195654339248
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.02031195654339248
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.02031195654339248
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.02031195654339248
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.02031195654339248
ZELLWEGER SYNDROME	0.000541419	0.02031195654339248
ALEXANDER DISEASE	0.000541419	0.02031195654339248
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.02031195654339248
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.02031195654339248
DIGEORGE SYNDROME; DGS	0.000541419	0.02031195654339248
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000541419	0.02031195654339248
PARTINGTON SYNDROME	0.000541419	0.02031195654339248
ACROCALLOSAL SYNDROME; ACLS	0.000541419	0.02031195654339248
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.02031195654339248
15Q24 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.02031195654339248
SMITH-FINEMAN-MYERS SYNDROME	0.000541419	0.02031195654339248
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.02031195654339248
FG SYNDROME TYPE 1	0.000541419	0.02031195654339248
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.02031195654339248
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.02031195654339248
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.02031195654339248
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.000541419	0.02031195654339248
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.02031195654339248
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000541419	0.02031195654339248
HEREDITARY FOLATE MALABSORPTION	0.000541419	0.02031195654339248
DIAMINOPENTANURIA	0.000541419	0.02031195654339248
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.02031195654339248
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.02031195654339248
DYSOSTEOSCLEROSIS	0.000541419	0.02031195654339248
FOLATE MALABSORPTION, HEREDITARY	0.000541419	0.02031195654339248
ARGININEMIA	0.000541419	0.02031195654339248
WALKER-WARBURG SYNDROME	0.000541419	0.02031195654339248
FOUNTAIN SYNDROME	0.000541419	0.02031195654339248
FRYNS SYNDROME; FRNS	0.000541419	0.02031195654339248
GAUCHER DISEASE, TYPE II	0.000541419	0.02031195654339248
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.02031195654339248
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.02031195654339248
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.000541419	0.02031195654339248
HARTNUP DISORDER	0.000541419	0.02031195654339248
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.02031195654339248
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.02031195654339248
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.000541419	0.02031195654339248
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000541419	0.02031195654339248
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.02031195654339248
GRISCELLI SYNDROME, TYPE 1	0.000541419	0.02031195654339248
CEREBROTENDINOUS XANTHOMATOSIS	0.000541419	0.02031195654339248
FRAGILE X SYNDROME	0.000541419	0.02031195654339248
COCKAYNE SYNDROME A; CSA	0.000541419	0.02031195654339248
COHEN SYNDROME	0.000541419	0.02031195654339248
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.02031195654339248
TEMTAMY SYNDROME; TEMTYS	0.000541419	0.02031195654339248
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.02031195654339248
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.02031195654339248
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.02031195654339248
CROME SYNDROME	0.000541419	0.02031195654339248
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000541419	0.02031195654339248
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.000541419	0.02031195654339248
STURGE-WEBER SYNDROME	0.000541419	0.02031195654339248
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.02031195654339248
SMITH-MAGENIS SYNDROME; SMS	0.000541419	0.02031195654339248
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.02031195654339248
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.02031195654339248
DERMOTRICHIC SYNDROME	0.000541419	0.02031195654339248
CORNELIA DE LANGE SYNDROME 1	0.000541419	0.02031195654339248
CROUZON SYNDROME	0.000541419	0.02031195654339248
DARIER-WHITE DISEASE; DAR	0.000541419	0.02031195654339248
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.02031195654339248
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.02031195654339248
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000541419	0.02031195654339248
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.02031195654339248
EPILEPSY, READING	0.000541419	0.02031195654339248
ZIMMERMANN-LABAND SYNDROME 1	0.000541419	0.02031195654339248
COFFIN-SIRIS SYNDROME 1; CSS1	0.000541419	0.02031195654339248
FLYNN-AIRD SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.02031195654339248
MYHRE SYNDROME	0.000541419	0.02031195654339248
PAPILLORENAL SYNDROME	0.000541419	0.02031195654339248
HADDAD SYNDROME	0.000541419	0.02031195654339248
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.000541419	0.02031195654339248
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.000541419	0.02031195654339248
1P36 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
POTOCKI-SHAFFER SYNDROME	0.000541419	0.02031195654339248
PELIZAEUS-MERZBACHER DISEASE	0.000541419	0.02031195654339248
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.02031195654339248
XQ28 (MECP2) DUPLICATION	0.000541419	0.02031195654339248
2Q33.1 DELETION SYNDROME	0.000541419	0.02031195654339248
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.02031195654339248
15Q13.3 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
SECONDARY SYRINGOMYELIA	0.000541419	0.02031195654339248
ADAMS-OLIVER SYNDROME 1; AOS1	0.000541419	0.02031195654339248
ADENYLOSUCCINASE DEFICIENCY	0.000541419	0.02031195654339248
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.02031195654339248
ANGELMAN SYNDROME	0.000541419	0.02031195654339248
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.02031195654339248
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000541419	0.02031195654339248
SPINOCEREBELLAR ATAXIA TYPE 13	0.000541419	0.02031195654339248
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.02031195654339248
HUNTINGTON DISEASE; HD	0.000541419	0.02031195654339248
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.02031195654339248
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.02031195654339248
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.02031195654339248
EMANUEL SYNDROME	0.000541419	0.02031195654339248
KOOLEN-DE VRIES SYNDROME	0.000541419	0.02031195654339248
RECOMBINANT 8 SYNDROME	0.000541419	0.02031195654339248
NON-DISTAL MONOSOMY 20Q	0.000541419	0.02031195654339248
OCULODENTODIGITAL DYSPLASIA; ODDD	0.000541419	0.02031195654339248
DISTAL MONOSOMY 10Q	0.000541419	0.02031195654339248
DISTAL MONOSOMY 19P13.3	0.000541419	0.02031195654339248
7Q11.23 MICRODUPLICATION SYNDROME	0.000541419	0.02031195654339248
8P INVERTED DUPLICATION/DELETION SYNDROME	0.000541419	0.02031195654339248
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.02031195654339248
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.02031195654339248
PRADER-WILLI SYNDROME; PWS	0.000541419	0.02031195654339248
RECOMBINANT CHROMOSOME 8 SYNDROME	0.000541419	0.02031195654339248
48,XXXY SYNDROME	0.000541419	0.02031195654339248
49,XXXXY SYNDROME	0.000541419	0.02031195654339248
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.02031195654339248
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.02031195654339248
PALLISTER-HALL SYNDROME	0.000541419	0.02031195654339248
KABUKI SYNDROME 1	0.000541419	0.02031195654339248
KBG SYNDROME	0.000541419	0.02031195654339248
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.02031195654339248
ADRENOMYODYSTROPHY	0.000541419	0.02031195654339248
ADAMS-OLIVER SYNDROME	0.000541419	0.02031195654339248
BOHRING-OPITZ SYNDROME	0.000541419	0.02031195654339248
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.02031195654339248
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.000541419	0.02031195654339248
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.02031195654339248
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.000541419	0.02031195654339248
HOLOPROSENCEPHALY 2; HPE2	0.000541419	0.02031195654339248
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.02031195654339248
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.02031195654339248
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000541419	0.02031195654339248
SIALIDOSIS TYPE 2	0.000541419	0.02031195654339248
MOWAT-WILSON SYNDROME; MOWS	0.000541419	0.02031195654339248
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000541419	0.02031195654339248
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.02031195654339248
HEREDITARY COPROPORPHYRIA	0.000541419	0.02031195654339248
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.02031195654339248
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000541419	0.02031195654339248
CLASSIC PHENYLKETONURIA	0.000541419	0.02031195654339248
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.02031195654339248
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.02031195654339248
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.02031195654339248
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000541419	0.02031195654339248
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.000541419	0.02031195654339248
PETERS-PLUS SYNDROME; PTRPLS	0.000541419	0.02031195654339248
PHENYLKETONURIA	0.000541419	0.02031195654339248
RAMON SYNDROME	0.000541419	0.02031195654339248
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000541419	0.02031195654339248
EPISODIC ATAXIA TYPE 3	0.000541419	0.02031195654339248
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.000541419	0.02031195654339248
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.02031195654339248
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.02031195654339248
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.000541419	0.02031195654339248
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000541419	0.02031195654339248
MOGS-CDG	0.000541419	0.02031195654339248
ALG9-CDG	0.000541419	0.02031195654339248
ALG1-CDG	0.000541419	0.02031195654339248
ALG2-CDG	0.000541419	0.02031195654339248
MPDU1-CDG	0.000541419	0.02031195654339248
DPM1-CDG	0.000541419	0.02031195654339248
ALG3-CDG	0.000541419	0.02031195654339248
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.02031195654339248
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.02031195654339248
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.02031195654339248
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.02031195654339248
NEURAMINIDASE DEFICIENCY	0.000541419	0.02031195654339248
ELEJALDE DISEASE	0.000541419	0.02031195654339248
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.02031195654339248
DEND SYNDROME	0.000541419	0.02031195654339248
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.02031195654339248
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.000541419	0.02031195654339248
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.02031195654339248
PYRUVATE DEHYDROGENASE DEFICIENCY	0.000541419	0.02031195654339248
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.02031195654339248
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.02031195654339248
WEAVER SYNDROME	0.000541419	0.02031195654339248
6Q TERMINAL DELETION SYNDROME	0.000541419	0.02031195654339248
ZUNICH NEUROECTODERMAL SYNDROME	0.000541419	0.02031195654339248
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.02031195654339248
PROTEUS SYNDROME	0.000541419	0.02031195654339248
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.02031195654339248
ADRENOLEUKODYSTROPHY	0.000541419	0.02031195654339248
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.02031195654339248
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000541419	0.02031195654339248
LISSENCEPHALY, X-LINKED, 2	0.000541419	0.02031195654339248
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.02031195654339248
THYROCEREBRORETINAL SYNDROME	0.000541419	0.02031195654339248
THREONINEMIA	0.000541419	0.02031195654339248
INFANTILE SIALIC ACID STORAGE DISEASE	0.000541419	0.02031195654339248
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.02031195654339248
RUBINSTEIN-TAYBI SYNDROME	0.000541419	0.02031195654339248
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.02031195654339248
RETT SYNDROME	0.000541419	0.02031195654339248
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.000541419	0.02031195654339248
MONOSOMY 9Q22.3	0.000541419	0.02031195654339248
INFANTILE REFSUM DISEASE	0.000541419	0.02031195654339248
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.02031195654339248
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.000541419	0.02031195654339248
SULFOCYSTEINURIA	0.000541419	0.02031195654339248
FILIPPI SYNDROME; FLPIS	0.000541419	0.02031195654339248
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.02031195654339248
TAY-SACHS DISEASE; TSD	0.000541419	0.02031195654339248
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.02031195654339248
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.02031195654339248
TRIPLE A SYNDROME	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.02031195654339248
MEHMO SYNDROME	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.02031195654339248
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000541419	0.02031195654339248
FETAL GAUCHER DISEASE	0.000541419	0.02031195654339248
KEUTEL SYNDROME	0.000541419	0.02031195654339248
GENITOPATELLAR SYNDROME	0.000541419	0.02031195654339248
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000541419	0.02031195654339248
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.02031195654339248
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.02031195654339248
KAPUR-TORIELLO SYNDROME	0.000541419	0.02031195654339248
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02031195654339248
TAY-SACHS DISEASE	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.000541419	0.02031195654339248
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.02031195654339248
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.02031195654339248
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000541419	0.02031195654339248
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.000541419	0.02031195654339248
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.02031195654339248
HYPER-BETA-ALANINEMIA	0.000541419	0.02031195654339248
DPAGT1-CDG	0.000541419	0.02031195654339248
HYPERLYSINEMIA, TYPE I	0.000541419	0.02031195654339248
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.02031195654339248
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000541419	0.02031195654339248
HYPERPROLINEMIA, TYPE II	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.02031195654339248
KETOADIPICACIDURIA	0.000541419	0.02031195654339248
KEUTEL SYNDROME; KTLS	0.000541419	0.02031195654339248
KIFAFA SEIZURE DISORDER	0.000541419	0.02031195654339248
LANDAU-KLEFFNER SYNDROME	0.000541419	0.02031195654339248
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.02031195654339248
SCLERODERMA	0.000541419	0.02031195654339248
47,XYY SYNDROME	0.000541419	0.02031195654339248
SCHIZENCEPHALY	0.000541419	0.02031195654339248
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.000541419	0.02031195654339248
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.02031195654339248
SANDHOFF DISEASE	0.000541419	0.02031195654339248
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000541419	0.02031195654339248
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.02031195654339248
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.02031195654339248
GRISCELLI SYNDROME TYPE 1	0.000541419	0.02031195654339248
PORPHYRIA VARIEGATA	0.000541419	0.02031195654339248
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000541419	0.02031195654339248
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.000541419	0.02031195654339248
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.02031195654339248
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000541419	0.02031195654339248
OHDO SYNDROME	0.000541419	0.02031195654339248
SIALIDOSIS TYPE 1	0.000541419	0.02031195654339248
MARDEN-WALKER SYNDROME	0.000541419	0.02031195654339248
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.02031195654339248
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.02031195654339248
CAMOS SYNDROME	0.000541419	0.02031195654339248
FREE SIALIC ACID STORAGE DISEASE	0.000541419	0.02031195654339248
MACDERMOT-WINTER SYNDROME	0.000541419	0.02031195654339248
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.000541419	0.02031195654339248
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.02031195654339248
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.02031195654339248
ISOLATED SPINA BIFIDA	0.000541419	0.02031195654339248
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.000541419	0.02031195654339248
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000541419	0.02031195654339248
SMITH-MAGENIS SYNDROME	0.000541419	0.02031195654339248
SMITH-LEMLI-OPITZ SYNDROME	0.000541419	0.02031195654339248
SJÖGREN-LARSSON SYNDROME	0.000541419	0.02031195654339248
MEND SYNDROME	0.000541419	0.02031195654339248
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.02031195654339248
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.02031195654339248
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.02031195654339248
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.000541419	0.02031195654339248
8P23.1 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
8P11.2 DELETION SYNDROME	0.000541419	0.02031195654339248
6Q25 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
3Q29 MICRODUPLICATION SYNDROME	0.000541419	0.02031195654339248
2Q31.1 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.02031195654339248
MICRO SYNDROME	0.000541419	0.02031195654339248
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000541419	0.02031195654339248
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
1Q21.1 MICRODUPLICATION SYNDROME	0.000541419	0.02031195654339248
1Q21.1 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
AICA-RIBOSIDURIA	0.000541419	0.02031195654339248
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000541419	0.02031195654339248
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.02031195654339248
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000541419	0.02031195654339248
CK SYNDROME	0.000541419	0.02031195654339248
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.02031195654339248
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.02031195654339248
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000541419	0.02031195654339248
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.000541419	0.02031195654339248
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
19P13.12 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.000541419	0.02031195654339248
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.02031195654339248
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.02031195654339248
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.02031195654339248
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.000541419	0.02031195654339248
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.000541419	0.02031195654339248
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.000541419	0.02031195654339248
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.000541419	0.02031195654339248
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000541419	0.02031195654339248
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.02031195654339248
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000541419	0.02031195654339248
JUVENILE HUNTINGTON DISEASE	0.000541419	0.02031195654339248
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02031195654339248
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.02031195654339248
4Q21 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
15Q11Q13 MICRODUPLICATION SYNDROME	0.000541419	0.02031195654339248
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.000541419	0.02031195654339248
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.000541419	0.02031195654339248
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02031195654339248
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.000541419	0.02031195654339248
DUBOWITZ SYNDROME	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.000541419	0.02031195654339248
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.02031195654339248
KBG SYNDROME	0.000541419	0.02031195654339248
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000541419	0.02031195654339248
DUANE RETRACTION SYNDROME	0.000541419	0.02031195654339248
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.02031195654339248
SANJAD-SAKATI SYNDROME	0.000541419	0.02031195654339248
KABUKI SYNDROME	0.000541419	0.02031195654339248
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.000541419	0.02031195654339248
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000541419	0.02031195654339248
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.02031195654339248
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.000541419	0.02031195654339248
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02031195654339248
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.02031195654339248
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.000541419	0.02031195654339248
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.000541419	0.02031195654339248
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.000541419	0.02031195654339248
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000541419	0.02031195654339248
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000541419	0.02031195654339248
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000541419	0.02031195654339248
RFT1-CDG	0.000541419	0.02031195654339248
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.000541419	0.02031195654339248
CENTRAL BILATERAL MACROGYRIA	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.000541419	0.02031195654339248
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.02031195654339248
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000541419	0.02031195654339248
KAGAMI-OGATA SYNDROME	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000541419	0.02031195654339248
KLEEFSTRA SYNDROME 2; KLEFS2	0.000541419	0.02031195654339248
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.02031195654339248
THANATOPHORIC DYSPLASIA	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000541419	0.02031195654339248
TRISOMY 8P	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.000541419	0.02031195654339248
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.000541419	0.02031195654339248
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.000541419	0.02031195654339248
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000541419	0.02031195654339248
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000541419	0.02031195654339248
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.000541419	0.02031195654339248
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.000541419	0.02031195654339248
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000541419	0.02031195654339248
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.02031195654339248
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000541419	0.02031195654339248
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.000541419	0.02031195654339248
JOUBERT SYNDROME 30; JBTS30	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.000541419	0.02031195654339248
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000541419	0.02031195654339248
OROFACIODIGITAL SYNDROME TYPE 6	0.000541419	0.02031195654339248
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000541419	0.02031195654339248
AL KAISSI SYNDROME; ALKAS	0.000541419	0.02031195654339248
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.000541419	0.02031195654339248
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.02031195654339248
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.02031195654339248
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.000541419	0.02031195654339248
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000541419	0.02031195654339248
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000541419	0.02031195654339248
KLEEFSTRA SYNDROME	0.000541419	0.02031195654339248
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.02031195654339248
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.02031195654339248
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.000541419	0.02031195654339248
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000541419	0.02031195654339248
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.000541419	0.02031195654339248
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000541419	0.02031195654339248
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.02031195654339248
JABERI-ELAHI SYNDROME; JABELS	0.000541419	0.02031195654339248
MOYNAHAN SYNDROME	0.000541419	0.02031195654339248
MOYAMOYA DISEASE	0.000541419	0.02031195654339248
MOMO SYNDROME	0.000541419	0.02031195654339248
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.000541419	0.02031195654339248
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.000541419	0.02031195654339248
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.000541419	0.02031195654339248
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.02031195654339248
MONOSOMY 9P	0.000541419	0.02031195654339248
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000541419	0.02031195654339248
14Q12 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.02031195654339248
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.02031195654339248
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
21Q22.11Q22.12 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
20P12.3 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000541419	0.02031195654339248
16Q24.3 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000541419	0.02031195654339248
CHROMOSOME 1P35 DELETION SYNDROME	0.000541419	0.02031195654339248
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.000541419	0.02031195654339248
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.02031195654339248
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
15Q14 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.000541419	0.02031195654339248
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.000541419	0.02031195654339248
COHEN SYNDROME	0.000541419	0.02031195654339248
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.02031195654339248
CANAVAN DISEASE	0.000541419	0.02031195654339248
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.02031195654339248
XQ21 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.000541419	0.02031195654339248
FRONTAL ENCEPHALOCELE	0.000541419	0.02031195654339248
RING CHROMOSOME 10 SYNDROME	0.000541419	0.02031195654339248
COFFIN-LOWRY SYNDROME	0.000541419	0.02031195654339248
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.02031195654339248
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.000541419	0.02031195654339248
COCKAYNE SYNDROME	0.000541419	0.02031195654339248
RING CHROMOSOME 22 SYNDROME	0.000541419	0.02031195654339248
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.02031195654339248
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000541419	0.02031195654339248
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.02031195654339248
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.02031195654339248
ISOLATED CEREBELLAR AGENESIS	0.000541419	0.02031195654339248
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.02031195654339248
17Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.02031195654339248
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.02031195654339248
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.02031195654339248
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.000541419	0.02031195654339248
COWDEN SYNDROME	0.000541419	0.02031195654339248
ACROCARDIOFACIAL SYNDROME	0.000541419	0.02031195654339248
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.02031195654339248
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.02031195654339248
EAST SYNDROME	0.000541419	0.02031195654339248
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.000541419	0.02031195654339248
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.02031195654339248
CORNELIA DE LANGE SYNDROME	0.000541419	0.02031195654339248
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.02031195654339248
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.000541419	0.02031195654339248
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.02031195654339248
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.02031195654339248
COFFIN-SIRIS SYNDROME	0.000541419	0.02031195654339248
COFS SYNDROME	0.000541419	0.02031195654339248
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.02031195654339248
HUNTINGTON DISEASE-LIKE 1	0.000541419	0.02031195654339248
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.02031195654339248
DISTAL MONOSOMY 15Q	0.000541419	0.02031195654339248
MONOSOMY 18Q	0.000541419	0.02031195654339248
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.02031195654339248
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.000541419	0.02031195654339248
1P36 DELETION SYNDROME	0.000541419	0.02031195654339248
2Q24 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.02031195654339248
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.02031195654339248
DISTAL MONOSOMY 3P	0.000541419	0.02031195654339248
DISTAL MONOSOMY 7Q36	0.000541419	0.02031195654339248
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.02031195654339248
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.000541419	0.02031195654339248
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.000541419	0.02031195654339248
MOSAIC TRISOMY 14	0.000541419	0.02031195654339248
DISTAL TRISOMY 15Q	0.000541419	0.02031195654339248
MULTIPLE CARBOXYLASE DEFICIENCY	0.000541419	0.02031195654339248
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000541419	0.02031195654339248
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.02031195654339248
ACROMELIC FRONTONASAL DYSPLASIA	0.000541419	0.02031195654339248
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.02031195654339248
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.000541419	0.02031195654339248
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.02031195654339248
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.02031195654339248
CRISPONI SYNDROME	0.000541419	0.02031195654339248
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.02031195654339248
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.02031195654339248
DYSEQUILIBRIUM SYNDROME	0.000541419	0.02031195654339248
FAMILIAL DYSAUTONOMIA	0.000541419	0.02031195654339248
22Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.02031195654339248
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.02031195654339248
KNOBLOCH SYNDROME	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.02031195654339248
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02031195654339248
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.000541419	0.02031195654339248
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.02031195654339248
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.02031195654339248
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.02031195654339248
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.02031195654339248
ROMANO-WARD SYNDROME	0.000541419	0.02031195654339248
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.000541419	0.02031195654339248
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.02031195654339248
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.02031195654339248
FLYNN-AIRD SYNDROME	0.000541419	0.02031195654339248
MATERNAL PHENYLKETONURIA	0.000541419	0.02031195654339248
JOUBERT SYNDROME WITH RENAL DEFECT	0.000541419	0.02031195654339248
JOUBERT SYNDROME WITH OCULAR DEFECT	0.000541419	0.02031195654339248
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.000541419	0.02031195654339248
CONGENITAL HYDROCEPHALUS	0.000541419	0.02031195654339248
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.02031195654339248
HYDRANENCEPHALY	0.000541419	0.02031195654339248
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.000541419	0.02031195654339248
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.02031195654339248
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.02031195654339248
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.000541419	0.02031195654339248
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.000541419	0.02031195654339248
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.02031195654339248
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.000541419	0.02031195654339248
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.000541419	0.02031195654339248
48,XXYY SYNDROME	0.000541419	0.02031195654339248
JACOBSEN SYNDROME	0.000541419	0.02031195654339248
2Q37 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02031195654339248
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.000541419	0.02031195654339248
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.02031195654339248
2Q23.1 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.02031195654339248
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.02031195654339248
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.02031195654339248
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000541419	0.02031195654339248
HALL-RIGGS SYNDROME	0.000541419	0.02031195654339248
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.000541419	0.02031195654339248
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.02031195654339248
BOWEN-CONRADI SYNDROME	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.02031195654339248
BRANCHIOSKELETOGENITAL SYNDROME	0.000541419	0.02031195654339248
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.000541419	0.02031195654339248
C SYNDROME	0.000541419	0.02031195654339248
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.02031195654339248
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.02031195654339248
GALLOWAY-MOWAT SYNDROME	0.000541419	0.02031195654339248
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.02031195654339248
FRYNS SYNDROME	0.000541419	0.02031195654339248
CRIGLER-NAJJAR SYNDROME	0.000541419	0.02031195654339248
FOIX-CHAVANY-MARIE SYNDROME	0.000541419	0.02031195654339248
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.000541419	0.02031195654339248
HARROD SYNDROME	0.000541419	0.02031195654339248
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.02031195654339248
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.02031195654339248
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.000541419	0.02031195654339248
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.02031195654339248
MOWAT-WILSON SYNDROME	0.000541419	0.02031195654339248
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.02031195654339248
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.02031195654339248
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.02031195654339248
DONNAI-BARROW SYNDROME	0.000541419	0.02031195654339248
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000541419	0.02031195654339248
BETA-MANNOSIDOSIS	0.000541419	0.02031195654339248
HENNEKAM SYNDROME	0.000541419	0.02031195654339248
HENNEKAM-BEEMER SYNDROME	0.000541419	0.02031195654339248
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.02031195654339248
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.000541419	0.02031195654339248
CYSTATHIONINURIA	0.000541419	0.02031195654339248
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.02031195654339248
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000541419	0.02031195654339248
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.000541419	0.02031195654339248
DISTAL TRISOMY 17Q	0.000541419	0.02031195654339248
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000541419	0.02031195654339248
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.000541419	0.02031195654339248
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.000541419	0.02031195654339248
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.000541419	0.02031195654339248
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.02031195654339248
COWDEN SYNDROME 5; CWS5	0.000541419	0.02031195654339248
COWDEN SYNDROME 6; CWS6	0.000541419	0.02031195654339248
TRISOMY 13	0.000541419	0.02031195654339248
GM1 GANGLIOSIDOSIS	0.000541419	0.02031195654339248
TRISOMY X	0.000541419	0.02031195654339248
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.02031195654339248
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.02031195654339248
LISSENCEPHALY 5; LIS5	0.000541419	0.02031195654339248
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000541419	0.02031195654339248
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.000541419	0.02031195654339248
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.02031195654339248
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.000541419	0.02031195654339248
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.02031195654339248
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000541419	0.02031195654339248
WILSON-TURNER SYNDROME	0.000541419	0.02031195654339248
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000541419	0.02031195654339248
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.000541419	0.02031195654339248
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000541419	0.02031195654339248
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.000541419	0.02031195654339248
SECKEL SYNDROME 7; SCKL7	0.000541419	0.02031195654339248
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.02031195654339248
GALACTOSIALIDOSIS	0.000541419	0.02031195654339248
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.02031195654339248
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.02031195654339248
FUCOSIDOSIS	0.000541419	0.02031195654339248
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000541419	0.02031195654339248
CHIME SYNDROME	0.000541419	0.02031195654339248
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.02031195654339248
WORSTER-DROUGHT SYNDROME	0.000541419	0.02031195654339248
WOLFRAM SYNDROME	0.000541419	0.02031195654339248
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.02031195654339248
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000541419	0.02031195654339248
THYROCEREBRORENAL SYNDROME	0.000541419	0.02031195654339248
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000541419	0.02031195654339248
SCHAAF-YANG SYNDROME; SHFYNG	0.000541419	0.02031195654339248
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000541419	0.02031195654339248
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.000541419	0.02031195654339248
FILIPPI SYNDROME	0.000541419	0.02031195654339248
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.02031195654339248
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000541419	0.02031195654339248
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000541419	0.02031195654339248
CHROMOSOME 5Q12 DELETION SYNDROME	0.000541419	0.02031195654339248
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.000541419	0.02031195654339248
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.02031195654339248
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.000541419	0.02031195654339248
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.02031195654339248
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000541419	0.02031195654339248
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.02031195654339248
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.000541419	0.02031195654339248
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000541419	0.02031195654339248
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.000541419	0.02031195654339248
TETRASOMY 9P	0.000541419	0.02031195654339248
TETRASOMY 5P	0.000541419	0.02031195654339248
TETRASOMY 18P	0.000541419	0.02031195654339248
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.02031195654339248
DUPLICATION/INVERSION 15Q11	0.000541419	0.02031195654339248
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.02031195654339248
MERCURY POISONING	0.000541419	0.02031195654339248
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.000541419	0.02031195654339248
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000541419	0.02031195654339248
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000541419	0.02031195654339248
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.000541419	0.02031195654339248
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.000541419	0.02031195654339248
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.000541419	0.02031195654339248
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000541419	0.02031195654339248
RENPENNING SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.000541419	0.02031195654339248
NOONAN SYNDROME 7; NS7	0.000541419	0.02031195654339248
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000541419	0.02031195654339248
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.02031195654339248
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.000541419	0.02031195654339248
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000541419	0.02031195654339248
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.02031195654339248
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.02031195654339248
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.000541419	0.02031195654339248
PONTINE TEGMENTAL CAP DYSPLASIA	0.000541419	0.02031195654339248
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.000541419	0.02031195654339248
LISSENCEPHALY 4	0.000541419	0.02031195654339248
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000541419	0.02031195654339248
SSR4-CDG	0.000541419	0.02031195654339248
STT3B-CDG	0.000541419	0.02031195654339248
STT3A-CDG	0.000541419	0.02031195654339248
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000541419	0.02031195654339248
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.000541419	0.02031195654339248
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000541419	0.02031195654339248
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.000541419	0.02031195654339248
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.000541419	0.02031195654339248
GABA-TRANSAMINASE DEFICIENCY	0.000541419	0.02031195654339248
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.02031195654339248
PRADER-WILLI-LIKE SYNDROME	0.000541419	0.02031195654339248
MAN1B1-CDG	0.000541419	0.02031195654339248
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.000541419	0.02031195654339248
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000541419	0.02031195654339248
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.02031195654339248
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.000541419	0.02031195654339248
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.02031195654339248
WITTEVEEN-KOLK SYNDROME	0.000541419	0.02031195654339248
RETT SYNDROME, CONGENITAL VARIANT	0.000541419	0.02031195654339248
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.000541419	0.02031195654339248
CHROMOSOME 19P13.13 DELETION SYNDROME	0.000541419	0.02031195654339248
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.02031195654339248
N-ACETYLASPARTATE DEFICIENCY; NACED	0.000541419	0.02031195654339248
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.000541419	0.02031195654339248
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.000541419	0.02031195654339248
DISTAL MONOSOMY 1Q	0.000541419	0.02031195654339248
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.02031195654339248
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.000541419	0.02031195654339248
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.000541419	0.02031195654339248
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.000541419	0.02031195654339248
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.02031195654339248
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000541419	0.02031195654339248
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000541419	0.02031195654339248
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.02031195654339248
COFFIN-SIRIS SYNDROME 2; CSS2	0.000541419	0.02031195654339248
COFFIN-SIRIS SYNDROME 3; CSS3	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.000541419	0.02031195654339248
COFFIN-SIRIS SYNDROME 4; CSS4	0.000541419	0.02031195654339248
19P13.13 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.02031195654339248
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.000541419	0.02031195654339248
20Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.02031195654339248
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.000541419	0.02031195654339248
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000541419	0.02031195654339248
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000541419	0.02031195654339248
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000541419	0.02031195654339248
PERRAULT SYNDROME 3	0.000541419	0.02031195654339248
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.02031195654339248
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.02031195654339248
ADAMS-OLIVER SYNDROME 2; AOS2	0.000541419	0.02031195654339248
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.02031195654339248
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.02031195654339248
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000541419	0.02031195654339248
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000541419	0.02031195654339248
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.02031195654339248
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.02031195654339248
10Q22.3Q23.3 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
MEVALONIC ACIDURIA	0.000541419	0.02031195654339248
CRONKHITE-CANADA SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.000541419	0.02031195654339248
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000541419	0.02031195654339248
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000541419	0.02031195654339248
CONGENITAL RUBELLA SYNDROME	0.000541419	0.02031195654339248
PITT-HOPKINS SYNDROME	0.000541419	0.02031195654339248
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.000541419	0.02031195654339248
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.000541419	0.02031195654339248
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000541419	0.02031195654339248
TARP SYNDROME	0.000541419	0.02031195654339248
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000541419	0.02031195654339248
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.02031195654339248
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.02031195654339248
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.000541419	0.02031195654339248
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.02031195654339248
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000541419	0.02031195654339248
LUSCAN-LUMISH SYNDROME; LLS	0.000541419	0.02031195654339248
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.02031195654339248
CHROMOSOME 16P13.2 DELETION SYNDROME	0.000541419	0.02031195654339248
11P15.4 MICRODUPLICATION SYNDROME	0.000541419	0.02031195654339248
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.000541419	0.02031195654339248
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.000541419	0.02031195654339248
SPONTANEOUS PERIODIC HYPOTHERMIA	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000541419	0.02031195654339248
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000541419	0.02031195654339248
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.02031195654339248
HEART AND BRAIN MALFORMATION SYNDROME	0.000541419	0.02031195654339248
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.02031195654339248
PORENCEPHALY	0.000541419	0.02031195654339248
COFFIN-SIRIS SYNDROME 5	0.000541419	0.02031195654339248
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.02031195654339248
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02031195654339248
ZTTK SYNDROME; ZTTKS	0.000541419	0.02031195654339248
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.000541419	0.02031195654339248
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.02031195654339248
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.02031195654339248
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.02031195654339248
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.000541419	0.02031195654339248
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000541419	0.02031195654339248
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02031195654339248
NASU-HAKOLA DISEASE	0.000541419	0.02031195654339248
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.02031195654339248
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.02031195654339248
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.000541419	0.02031195654339248
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.000541419	0.02031195654339248
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000541419	0.02031195654339248
MICROFORM HOLOPROSENCEPHALY	0.000541419	0.02031195654339248
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.000541419	0.02031195654339248
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.000541419	0.02031195654339248
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.02031195654339248
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000541419	0.02031195654339248
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000541419	0.02031195654339248
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.000541419	0.02031195654339248
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000541419	0.02031195654339248
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.000541419	0.02031195654339248
XP22.13P22.2 DUPLICATION SYNDROME	0.000541419	0.02031195654339248
TYROSINEMIA TYPE 2	0.000541419	0.02031195654339248
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000541419	0.02031195654339248
IMMUNODEFICIENCY 49; IMD49	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000541419	0.02031195654339248
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.02031195654339248
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000541419	0.02031195654339248
LISSENCEPHALY 8; LIS8	0.000541419	0.02031195654339248
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.000541419	0.02031195654339248
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.000541419	0.02031195654339248
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.000541419	0.02031195654339248
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.000541419	0.02031195654339248
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.02031195654339248
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.02031195654339248
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.02031195654339248
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.02031195654339248
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.000541419	0.02031195654339248
SEVERE CANAVAN DISEASE	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.02031195654339248
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000541419	0.02031195654339248
CATEL-MANZKE SYNDROME; CATMANS	0.000541419	0.02031195654339248
QAZI-MARKOUIZOS SYNDROME	0.000541419	0.02031195654339248
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000541419	0.02031195654339248
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.000541419	0.02031195654339248
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000541419	0.02031195654339248
20P13 MICRODELETION SYNDROME	0.000541419	0.02031195654339248
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.02031195654339248
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.000541419	0.02031195654339248
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.02031195654339248
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.02031195654339248
WIEDEMANN-STEINER SYNDROME	0.000541419	0.02031195654339248
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000541419	0.02031195654339248
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000541419	0.02031195654339248
FOUNTAIN SYNDROME	0.000541419	0.02031195654339248
AICARDI-GOUTIERES SYNDROME 7	0.000541419	0.02031195654339248
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000541419	0.02031195654339248
HELSMOORTEL-VAN DER AA SYNDROME	0.000541419	0.02031195654339248
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.02031195654339248
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.000541419	0.02031195654339248
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.02031195654339248
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.000541419	0.02031195654339248
HEREDITARY HYPEREKPLEXIA	0.000541419	0.02031195654339248
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.000541419	0.02031195654339248
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.02031195654339248
WEBB-DATTANI SYNDROME; WEDAS	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000541419	0.02031195654339248
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.000541419	0.02031195654339248
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000541419	0.02031195654339248
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000541419	0.02031195654339248
RUVALCABA SYNDROME	0.000541419	0.02031195654339248
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000541419	0.02031195654339248
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.000541419	0.02031195654339248
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.02031195654339248
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000541419	0.02031195654339248
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.02031195654339248
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.000541419	0.02031195654339248
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.02031195654339248
DESANTO-SHINAWI SYNDROME	0.000541419	0.02031195654339248
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.000541419	0.02031195654339248
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000541419	0.02031195654339248
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.000541419	0.02031195654339248
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.000541419	0.02031195654339248
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000541419	0.02031195654339248
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.000541419	0.02031195654339248
RAMON SYNDROME	0.000541419	0.02031195654339248
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.02031195654339248
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.000541419	0.02031195654339248
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.000541419	0.02031195654339248
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.000541419	0.02031195654339248
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000541419	0.02031195654339248
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.000541419	0.02031195654339248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000541419	0.02031195654339248
ATYPICAL RETT SYNDROME	0.000541419	0.02031195654339248
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.000541419	0.02031195654339248
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.000541419	0.02031195654339248
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000541419	0.02031195654339248
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.02031195654339248
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.02031195654339248
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000541419	0.02031195654339248
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000541419	0.02031195654339248
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.02031195654339248
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.000541419	0.02031195654339248
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.02031195654339248
